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Abstract
Cell migration is a key aspect of many normal and abnormal biological
processes, including embryonic development, defense against infections, wound
healing, and tumor cell metastasis. In this study we demonstrate that an epithelial
cell actin-binding protein, villin, plays a crucial role in the process of cell
migration. Overexpression of villin in doxycyline-regulated HeLa Tet-off and
MDCK Tet-off cells enhanced cell migration. We further demonstrate that
tyrosine phosphorylation of villin by c-src is required for villin-induced cell
migration. Previously, we identified four tyrosine phosphorylation sites in the
amino-terminal domain of villin. I further identified six new sites in the carboxylterminal region of the villin core. Collectively we have now documented all
phosphorylatable tyrosine residues in villin and mapped them to villin’s functions.
To further investigate the role of tyrosine phosphorylation sites in cell migration,
we used phosphorylation site mutants (tyrosine to phenylalanine or tyrosine to
glutamic acid) stably transfected in HeLa and MDCK Tet-off cells. We determined
that tyrosine phosphorylation at amino-terminus of villin played an essential role
in cell migration as well as in the reorganization of the actin cytoskeleton. The
carboxyl-terminal phosphorylation sites were found to be critical for villin’s
interaction with its ligand PLC-γ1 and for its localization to the developing
lamellipodia in a motile cell. Collectively, these studies define how biophysical
events such as cell migration are actuated by biochemical signaling pathways
involving tyrosine phosphorylation of actin binding proteins, in this case villin.
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Chapter 1
Introduction

1

1.1 The actin cytoskeleton
The actin cytoskeleton is a fundamental component of all eukaryotic cells.
It provides force and stability and plays an integral role in a diverse array of
cellular processes. Actin is mainly located in the cytoplasm, but it is also present
in the nucleus where it may or may not have motor-associated functions. Actin
filaments are particularly abundant beneath the plasma membrane, where they
form a network that provides mechanical support, determines cell shape, and
allows movement of the cell surface, thereby enabling cells to migrate.
Actin exists as a globular monomer called G-actin and as a filamentous polymer
called F-actin, which is a linear chain of G-actin subunits. G-actin has a
molecular mass of approximately 43 kDa. Although G-actin appears globular in
the electron microscope, x-ray crystallographic analysis reveals that it is
separated into two lobes by a deep cleft. The deep cleft has a tightly bound
nucleotide in the center of G-actin. The nucleotide binds as a complex with either
Mg2+ or Ca2+. This nucleotide is usually ATP or ADP-Pi rather than ADP. ADP-Pi
binds with ~ 10-fold lower affinity to Mg2+-G-actin and ~ 200-fold lower affinity
with Ca2+-G-actin compared to ATP (ATP-Mg2+ dissociation constant (kd) is 1.2
nM and ATP-Ca2+ kd is 0.12 nM) (De La Cruz and Pollard, 1995; StrzeleckaGolaszewska, 2001). Hence, Mg2+, the dominant cation in vivo, determines the
binding affinity of the nucleotide to G-actin. The nucleotide binding to G-actin
affects the conformation of the molecule. In fact, without a bound nucleotide, Gactin denatures very quickly (De La Cruz and Pollard, 1995).
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G-actin has high affinity binding sites that mediate head-to-tail interactions
with two other G-actin molecules, thus actin monomers polymerize to form Factin nuclei (figure 1.1). G-actin monomers are then added to the nuclei to
assemble filamentous actin (F-actin). Each monomer is rotated by 166° in the
filaments, which gives it the appearance of a double-stranded helix (Holmes et
al., 1990). Because all the actin monomers are oriented in the same direction,
actin filaments have a distinct polarity, and their ends (called the barbed ends or
plus ends and pointed ends or minus ends) are distinguishable from one another
(figure 1.1). The addition of ions — Mg2+, K+, or Na+— to a solution of G-actin will
induce the polymerization of G-actin into F-actin filaments. The process is
reversible: F-actin depolymerizes into G-actin when the ionic strength of the
solution is lowered. The F-actin filaments that form in vitro are indistinguishable
from microfilaments isolated from cells. This indicates that other factors such as
actin binding proteins are not required for polymerization per se. However the
presence of actin-binding proteins in cell results in a 100 times faster turnover of
actin filaments. Actin polymerization from monomers proceeds in at least four
reversible steps: activation, nucleation, elongation and annealing. Activation is a
conformational change in G-actin monomer induced by salts. Nucleation is the
association of 2 to 3 monomers to form oligomers from which polymer can grow
(figure 1.1). These two steps are much slower than elongation and account for
the initial lag phase in the time course of actin polymerization in vitro. Elongation
involves association and dissociation of monomers from the filament. These
processes can occur at either end of the filament, but association predominantly

3

pointed end

nucleation

polymerization

barbed end
G-actin

Nuclei

F-actin
ADP-G-actin
ATP-G-actin

Figure 1.1 G-actin polymerizes to form F-actin. Two to three monomers of ATP
bound G-actin polymerize to form the nuclei. Addition of ATP-G-actin at the
barbed end in a polymerization reaction forms F-actin. Filaments age by
hydrolysis of ATP bound to each ATP-G-actin subunit followed by dissociation of
the γ phosphate, which result in actin filaments with ADP-G-actin.
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occurs at the barbed end and dissociation at the pointed end as discussed
below. Short actin filaments can also anneal end to end, leading over time to an
increase in filament length (annealing). The nucleotide binding site of monomeric
actin is almost exclusively associated with ATP in vivo. While the G-actin bound
ATP is readily exchangeable, the ADP of F-actin is essentially nonexchangable
(Hegyi et al., 1988). Hydrolysis of bound ATP was originally thought to be tightly
coupled to the polymerization process (Wegner, 1976); however subsequent
investigation (Carlier et al., 1984; De La Cruz et al., 2000) revealed that a time
lag exists between the incorporation of ATP-G-actin onto the filament end and
hydrolysis of the bound nucleotide. This results in the formation of an ATP-Gactin cap at the barbed end which facilitates faster polymerization at the barbed
end (figure 1.1). Because actin polymerization is reversible, filaments can
depolymerize by the dissociation of ADP-G-actin subunits from the pointed end.
Thus, an apparent equilibrium exists between actin monomers and filaments,
which are dependent on the concentration of free monomers. The rate at which
actin monomers are incorporated into filaments is proportional to their
concentration, so there is a critical concentration of actin monomers at which the
rate of their polymerization into filaments equals the rate of dissociation. At this
critical concentration, monomers and filaments are in apparent equilibrium.
As noted earlier, the two ends of an actin filament grow at different rates,
with monomers being added to the fast-growing end (barbed or plus) five to ten
times faster than to the slow-growing (pointed or minus) end. Because ATP-actin
(barbed

end)

dissociates

less

readily
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than

ADP-actin

(pointed

end),

depolymerization of actin filaments always occurs at the pointed end. This results
in a difference in the critical concentration of monomers needed for
polymerization at the two ends. The critical concentration for the pointed end is
12 to 15 -fold higher than for the barbed end under physiological conditions
(Wegner and Isenberg, 1983). This difference may result in the unidirectional
growth of the actin filament due to a continual flux of actin subunits from the
pointed to the barbed end of the filament. This reaction is called treadmilling
(Wegner, 1976). Treadmilling requires ATP, with ATP-G-actin being added at the
barbed end of filaments while ADP-G-actin being removed from the pointed end.
The role of treadmilling at the leading edge of a moving cell was clearly
demonstrated by use of fluorescent speckle microscopy (Ponti et al., 2004). Actin
treadmilling at the leading edge results in the dynamic assembly and
disassembly of actin filaments in an efficient unidirectional manner required for
cells to change shape and move.

1.2 Villin: An actin binding protein
In cells the assembly and disassembly of actin filaments, and also their
organization into functional higher-order networks, is regulated by a plethora of
actin-binding proteins (ABPs). The turnover of actin filaments is about 100 times
faster within the cell than it is in vitro, and this rapid turnover of actin plays a
critical role in a variety of cell movements. Villin is an epithelial cell specific actinbinding protein. Villin is a 92.5 kDa protein consisting of two tandem homologous
halves

(segments

1-3

and

4-6,

S1-S6)

6

and

a

head

piece

domain

(segment 7, S7) (figure 1.2). The segments 1 through 6 are all structural repeats
that are conserved amongst villin family of proteins which includes (but not
limited to) gelsolin, adseverin (also known as scinderin), CapG, severin (aka
fragmin), advillin, and supervillin. All of these proteins contain at least one of the
structural repeats. For example gelsolin and adseverin are a six-domain ABP;
CapG only has the first three domains, whereas advillin and supervillin have six
domains and also share a villin-like carboxyl-terminal headpiece domain. Among
all actin-binding proteins, villin is unique in presenting capping, bundling,
polymerizing and severing properties in a single protein. An important question is
how does villin regulate these different actin modifying activities? The work done
in our lab has significantly contributed to our understanding of this important and
complex question. Our studies show that the ligand-binding properties and posttranslational modification of villin protein regulate the actin modifying activities of
villin (see discussion below).

1.2.1 PIP2 regulates actin-severing, -capping and -crosslinking activity of
villin. In vitro interaction of full length villin protein with phosphoinositide 4, 5
bisphosphate (PIP2) was first characterized by our lab (Panebra et al., 2001).
Using site directed mutagenesis we identified three PIP2 binding sites in human
villin, PB1 (a.a. 112-119), PB2 (a.a. 138-146) and PB5 (a.a. 816-824), (figure
1.2). These sites contain the consensus sequence for phosphoinositide binding
also found in other cytoskeletal proteins, and consists of basic amino acids with
the following motif, (X)4(R/K)(X)(R/KR/K) (Kumar et al., 2004b). Two of the PIP2
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Y46
Y60
Y64

Y81

F-actin

S1

S2

Ca2+

Y256

F-actin
S3

S4

S5

S6

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

148 188

265 309

407 457

528 568

631 672

H

PB1
27

76

PB2

735 827

PB5

Figure 1.2 Schematic representation of villin. Segmental repeats are represented
by S1 through S6. The letter H represents the headpiece. Ca2+ binding sites
depicted in segments S1 represent Ca2+ binding site 1 and the site depicted in
segment S2 represents the intradomain Ca2+ binding site 2. Sites depicted in
segment S3 through S6 represent the other intradomain Ca2+ binding sites in
villin. F-actin binding sites, PIP2 binding sites (PB1, PB2 and PB5) and tyrosine
phosphorylation sites (Y-46, -60, -64, -81 and -256) are also schematically
represented.

8

binding sites identified by us described actin-binding sites in villin (Kumar et al.,
2004b). PB2 has been described as the site of F-actin binding to villin prior to
severing, and PB5 has been identified as the F-actin-binding site involved in the
bundling function of villin. However a more recent high resolution crystal
structures of chicken villin head piece, has established that most of the residues
in PB5 are dispensable for F-actin binding (Meng et al., 2005). Thus, PB5 is a
PIP2 binding site in proximity of the F-actin binding site in villin headpiece. The
third lipid-binding site PB1, lies in the vicinity of an actin monomer-binding site
(a.a. 72-99) in other proteins of the villin family such as gelsolin and by homology
in villin (Bretscher and Weber, 1980). PB1 and PB2 lie in the actin capping and
severing domain of villin and are conserved among the actin-capping and
-severing proteins, whereas PB5 lies in close vicinity of the actin cross-linking
domain in the headpiece of villin and is conserved among proteins that contain a
villin-like headpiece (figure 1.2). We further demonstrated that Arg 138 in PIP2
binding domain PB2 determines 80% of the PIP2 binding and as previously
reported 83% of the actin-severing activity of villin (De Arruda et al., 1992; Kumar
et al., 2004b). This suggests that PIP2 binding to villin in the actin severing
domain (PB2) can directly inhibit the actin-severing activity of villin by competitive
inhibition. Interestingly deletion of PB1 also inhibits actin-severing activity of villin.
PB1 has been described as the site that stabilizes the binding of F-actin to PB2,
and PIP2 binding to PB1 results in a change in the secondary structure of PB1.
This suggests that PIP2 -induced structural changes in villin could also influence
the actin-severing activity of villin in vivo. Like severing PIP2 also inhibited the

9

capping activity of villin (Kumar et al., 2004b). PIP2 enhances the actincrosslinking activity of villin (Kumar et al., 2004b). We have recently
demonstrated that PIP2 facilitates dimerization of villin (George et al., 2006). We
further demonstrated that the F-actin binding site in the villin headpiece is
sufficient for actin-bundling activity of villin, provided villin is dimerized. Hence,
PIP2 can regulate the actin-bundling activity of villin by regulating villin selfassociation. The only actin modifying function of villin that is not regulated by
PIP2 is actin-nucleation (Kumar et al., 2004b).

1.2.2 Calcium regulates villin’s actin-severing and -capping activity. It has
been shown previously that villin directly binds to calcium and can regulate the
actin-capping and -cutting activities of villin (Glenney et al., 1980; Hesterberg and
Weber, 1983a; Walsh et al., 1984). It has also been reported before that in the
presence of calcium, there is an increase in the Stoke’s radius of villin, indicative
of a Ca2+ -induced conformational change, which was confirmed by circulardichroism studies (Hesterberg and Weber, 1983b). The work done in our lab has
demonstrated that two low affinity Ca2+ -sensitive sites (aspartic acid 467 and
715) interact with a cluster of basic residues in the S2 domain of villin, resulting in
an auto-inhibited conformation of villin. A Ca2+ concentration of > 100 µM causes
a conformational change in villin. A similar change in villin conformation can be
obtained by mutation of aspartic acid 467 and 715 to leucine, allowing villin to
sever F-actin at physiological Ca2+ concentration (Kumar and Khurana, 2004).
Hence, Ca2+ can regulate the structure and function of villin. With the help of site
directed mutagenesis, using the NMR structure of villin 14T (Markus et al., 1994)
10

and the gelsolin-actin/ Ca2+crystal structure (Burtnick et al., 1997) our lab
identified six additional sites that result in Ca2+ induced conformational changes
in villin. Furthermore, we determined that villin expresses at least two types of
Ca2+ sensitive sites that determine separate functional properties; site 1 (Glu-25,
Asp-44, and Glu-74) regulates actin-capping, whereas sites 1 and 2 (Asp-86,
Ala-93, and Asp-61), together with the intra-domain calcium-sensitive sites in
villin, regulate actin-severing by villin ((Kumar et al., 2004a), (figure 1.2)). Hence,
Ca2+ binding to villin can functionally dissect the actin-capping and -severing
activities of villin. Although half-maximal capping is obtained at Ca2+
concentration of 1 µM, half-maximal severing by villin requires more than 100 µM
Ca2+. Our data then suggests that site 1 may be a high affinity Ca2+ binding site
which could regulate the actin-capping activity of villin at low Ca2+ concentrations
(2.5 µM). Whereas site 2 and other intra-domain calcium sensitive sites in villin
may be low affinity Ca2+ binding sites, which could regulate

actin-severing

activity of villin at calcium concentrations greater than 100 µM (Kumar et al.,
2004a). Hence, the high affinity and low affinity Ca2+ binding sites could result in
a conformational change in villin from an auto-inhibited state to an active state,
capable of capping (2.5 µM Ca2+) and severing actin filaments (> 100 µM Ca2+)
respectively.

1.2.3

Tyrosine

phosphorylation

of

villin

regulates

actin-severing,

-nucleation and -bundling activities of villin. The Ca2+ concentrations required
for actin-severing by villin are in the micromolar range (~200 µM), which suggests
that in vivo functional regulation of villin may not be regulated by Ca2+, since
11

intracellular Ca2+ levels may never reach 200 µM (Villereal and Palfrey, 1989). To
resolve this paradox we looked at the role of post-translational modification of
villin, in the form of tyrosine (Y) phosphorylation. Our lab was the first to show
that villin is tyrosine phosphorylated (Khurana et al., 1997). Five phosphorylation
sites were identified by direct mutation of candidate tyrosine’s (Y) to
phenylalanine (F), namely, Y46, -60, -64, -81, and -256 (figure 1.2). These sites
could be phosphorylated by c-src kinase in an in vitro kinase assay, suggesting
that c-src may be involved in phosphorylation of villin in cells (Zhai et al., 2002).
We determined that tyrosine phosphorylated villin had enhanced actin-severing
activity compared to unphosphorylated villin. Tyrosine phosphorylation of villin
also resulted in actin-severing at nanomolar Ca2+ concentrations, suggesting that
tyrosine phosphorylation and not Ca2+ may be the physiological regulator of
villin’s actin-severing activity (Zhai et al., 2002; Kumar and Khurana, 2004).
Characterization of individual tyrosine phosphorylation sites in the aminoterminus of villin revealed that phosphorylation at Y46 or -60 increased the actinsevering activity of villin (Zhai et al., 2002). Tyrosine phosphorylation of villin also
inhibited its actin-nucleating activity (Zhai et al., 2001; Zhai et al., 2002). Since
phosphorylation of villin decreases its affinity for F-actin, it provides a
mechanism for inhibition of villin’s actin-nucleating activity (Zhai et al., 2001; Zhai
et al., 2002). Unlike severing no individual tyrosine phoshorylation site of villin
regulated actin-nucleation by villin, suggesting that two or more of the identified
tyrosine phosphorylation sites may regulate actin-nucleation by villin (Zhai et al.,
2001; Zhai et al., 2002). Actin-crosslinking activity of villin is also inhibited by

12

tyrosine phosphorylation. We have recently demonstrated that tyrosine
phosphorylation of villin prevents villin dimerization, which in turn results in
inhibition of actin-crosslinking by villin (George et al., 2006).

1.3 Cell migration
Cell migration is a key aspect of many normal and abnormal biological
processes, including embryonic development, defense against infections, wound
healing, and tumor cell metastasis (Trinkaus, 1988; Martin, 1997; Nodder and
Martin, 1997).

As shown in figure 1.3

almost universally, crawling motility

involves a cycle of four steps: protrusion of the leading edge, adhesion to the
substratum, retraction of the rear, and de-adhesion (Abercrombie et al., 1972).
In response to various migratory cues, directional movement is initiated by
polarization of the cell, as defined by the spatial segregation of molecular
machineries that control the four stages of the migratory cycle. At the front of the
cell, actin polymerization drives membrane protrusion to form the leading edge.
Subsequently, the leading edge is stabilized by attachment to the extracellular
matrix (ECM) through integrin-mediated adhesion complexes, which not only link
the ECM to the actin cytoskeleton but also function as signal transduction centers
that modulate cell migration. Once coupled to adhesion complexes, the actin
cytoskeleton can generate the forces necessary to translocate the cell body
forward. Finally, adhesive contacts at the rear of the cell must be disassembled to
allow detachment of the rear to complete the migratory cycle.
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Figure 1.3 Simplified model of cell motility. Almost universally, crawling motility
involves a cycle of four steps: (1) protrusion of the leading edge in response to a
signal, (2) adhesion to the substratum, (3) retraction of the rear, and (4) deadhesion.
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The first step in locomotion, protrusion of a leading edge, seems to rely
only on forces generated by actin polymerization pushing the plasma membrane
outward. Motile cells primarily generate two types of protrusive structures,
filopodia (also known as microspikes) and lamellipodia. These protrusive
structures are filled with a dense core of filamentous actin, which excludes
membrane-enclosed organelles. Filopodia and lamellipodia differ primarily in the
way in which the actin is organized. Filopodia are essentially made up of long,
bundled actin filaments, which are reminiscent of those in microvilli but longer
and thinner, as well as more dynamic. Lamellipodia are sheet-like structures,
they contain an orthogonally cross-linked mesh of actin filaments, most of which
lie in a plane parallel to the solid substratum. (DeMali and Burridge, 2003).
Filopodia are postulated to increase directional motility by acting as
environmental sensors (Bryant, 1999). Lamellipodia contains all of the machinery
that is required for cell motility. Understanding how actin is assembled at the
leading edge can provide important insight into the molecular mechanism(s) of
cell migration. The next section describes the machinery that is required for the
initiation and formation of lamellipodia.

1.3.1 Role of Rho family GTPases in lamellipodia formation. The signalling
pathways that initiate lamellipodia formation are somewhat obscure; however it is
clear that Rho family guanosine tri-phosphatases (GTPases) play a central role.
These proteins (Rac, Cdc 42 and Rho) act as molecular switches cycling
between an active GTP and inactive GDP-bound forms. Despite being
membrane-anchored via their isoprenylated carboxy-termini, Rho GTPases
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rapidly translocate between membrane and cytosolic compartments. The role of
Rho family GTPases has been revealed by simple microinjection experiments.
Microinjection of activated Rac into fibroblasts induced dramatic lamellar ruffling
driven by de novo actin polymerization (Ridley and Hall, 1992; Machesky and
Hall, 1997). Dominant negative Rac mutant blocked motility of macrophages and
prevented membrane ruffling in stimulated fibroblasts (Ridley and Hall, 1992).
Injection of Cdc 42 into fibroblast resulted in the formation of filopodia (Kim et al.,
2000). When Rho protein was microinjected into fibroblasts it resulted in the rapid
assembly of stress fibers and focal adhesions but did not have any influence on
the lamellipodia formation. Hence, in response to various migratory cues Rac
and Cdc 42 are activated at the leading edge of a motile cell and are crucial for
lamellipodia protrusion. In contrast Rho is activated at the trailing edge of the cell
and is responsible for cell contraction at the trailing edge (figure 1.4).

1.3.2 Role of actin in lamellipodia formation. Rapid changes in the levels of Factin and G-actin that occur in a spatially and temporally controlled fashion are
involved in the morphological changes in living cells. Observation of actin
dynamics in motile cells indicates that not only are actin filaments actively
polymerizing beneath the plasma membrane at the leading edge, but also the
turnover of actin filaments is faster (for instance during actin treadmilling) in the
lamellipodia than in other regions of the cell (Condeelis, 1993). Lamellipodia
extension requires assembly of a specialized network of actin filaments at the
leading edge of the cell. F-actin in lamella is mainly present in the form of crosslinked network which are several microns long and organized into two nearly
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Figure 1.4 Role of Rho GTPases in cell migration. Rac and Cdc 42 are activated
at the leading edge of a motile cell. Activation of Rac results in the formation of
lamellipodia, whereas activation of Cdc 42 results in the formation of filopodia.
Rho is activated at the trailing edge of the cell and is responsible for cell
contraction at the trailing edge.
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parallel two-dimensional arrays, approximately orthogonal to each other (Small
et al., 1995). Closer to the membrane (within 1µM) is a population of very short
filaments that are organized into an extensive network of Y-branches (Svitkina
and Borisy, 1999). This specialized arrangement of F-actin in the lamella is
responsible for the formation and growth of lamellipodia in a moving cell.

1.3.3 Role of actin binding proteins in lamellipodia formation. Cells are
endowed with a rich variety of actin binding proteins, falling into more than 60
classes. Actin and a limited subset of actin binding proteins can reconstitute
motility in a purified system. These include ADF/cofilin, Cap Z, Arp2/3 complex,
an activator of Arp2/3 complex and profilin (Loisel et al., 1999). Many other actin
binding proteins including villin family of proteins have been shown to play an
important role in cell migration and lamellipodia formation, but for purposes of
simplicity, I will concentrate on these core proteins.
Profilin binds ATP-actin monomers in a stable 1:1 complex and is
essentially a high-affinity monomer binding protein. Rather than sequestering
actin monomers (which is also achieved by other monomer binding proteins like
thymosin), the main function of profilin is to promote assembly of actin filaments
in cells (Lu and Pollard, 2001). Profilin in complex with ATP-G-actin is postulated
to assist in addition of monomers exclusively at the barbed end of an actin
filament. After the complex binds transiently to the filament, the profilin
dissociates from actin. Profilin also binds to proline-rich sequences that are
commonly found in membrane-associated signaling proteins such as formins,
Vasp and Mena. This interaction, which does not inhibit profilin binding to G18

actin, localizes profilin-actin complexes to the membrane (Lu and Pollard, 2001).
Profilin also promotes assembly of actin filaments by acting as a nucleotideexchange factor. Profilin is the only actin binding protein that allows the
exchange of ADP for ATP. Profilin regulates actin treadmilling as it converts the
ADP-G-actin released from the pointed end of actin filaments to ATP-G-actin that
can be added to the barbed end of actin filaments. (Pollard and Borisy, 2003).
Hence, profilin plays an important role in actin polymerization at the leading
edge.
At the leading edge the barbed ends of actin filament are always oriented
towards the membrane. As a result, actin polymerization at the barbed end
generates membrane protrusion. Most filament depolymerization occurs at sites
located well behind the leading edge. ADF/Cofilin accelerates the actin
depolymerization at the pointed end thus playing an important role in cell
migration. Cofilin binds cooperatively and preferentially to pointed end of actin
filaments, containing ADP-actin, and not at the barbed end containing ATP-actin,
causing enhanced rate of monomer dissociation from the pointed end. The ADPactin released from the pointed end is then converted to ATP-actin by profilin as
described above. Hence, ADF/cofilin along with profilin plays an essential role in
actin treadmilling, which maintains efficient, unidirectional actin-polymerization in
the lamellipodium.
Cap Z a heterodimeric capping protein is a ubiquitous barbed end capping
protein which prevents actin assembly from barbed ends. Capping may appear
counter-productive in cell motility, since it antagonizes elongation of barbed ends,
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the driving force for motility. However, capping makes two important contributions
to actin-driven motility. First, capping proteins limit the length of the growing
branches. Short filaments are stiffer than long filaments and therefore more
effective at pushing the membrane. Second, capping controls where actin
filaments “push”. Since only those barbed ends in contact with the lamellipodial
surface are effective in generating propulsive force, global capping of barbed
ends avoids non-productive consumption of actin subunits elsewhere in the cell
and funnels subunits from diverse points of disassembly to a limited number of
growing barbed ends (Carlier and Pantaloni, 1997; Cooper and Schafer, 2000;
Pollard and Borisy, 2003).
The formation and growth of lamellipodia in a moving cell needs to be
fuelled by continuous new F-actin filaments nuclei. Severing of existing filaments,
uncapping of existing filaments or de novo nucleation can all result in the
formation of new actin nuclei. However de novo creation of new nuclei is now
considered to be the dominant mechanism in the leading edge (Zigmond, 1996).
Arp2/3 complex has the ability to form de novo actin filaments. Arp2/3 complex is
a stable assembly of two actin-related proteins, Arp2 and Arp3, with five novel
subunits called ARPC1, ARPC2, ARPC3, ARPC4 and ARPC5 (Machesky et al.,
1994). Biochemical and cell biology experiments established that the Arp2/3
complex caps pointed ends and initiates growth in the barbed end direction at
70° branches identical to actin filament branches (Y-branches) seen in growing
lamellipodia (Mullins et al., 1998). The Arp2/3 complex sits at the Y branch
between the filaments and stabilizes the cross-link both in vitro and in vivo.
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Coordination of these two activities of the Arp2/3 complex is thought to
simultaneously generate new filaments and connect them together in
approximately orthogonal networks in cells.
Purified Arp2/3 complex possesses little activity on its own, but it can be
activated by a class of proteins called nucleation promoting factors (NPFs) that
are highly conserved from bacteria to mammals (Mullins et al., 1998). These
include the Listeria monocytogenes ActA protein (Welch et al., 1998), and the
evolutionary conserved Wiskott-Aldrich syndrome protein (WASP), among others
(Rohatgi et al., 1999; Winter et al., 1999). Based on this information a model has
been proposed called the “dendritic model” which also explains the quantitative
mechanism of lamellipodia formation and growth (figure 1.5). The model
proposes that, in the absence of new actin nuclei, cytoskeletal components are
held in a metastable state, poised for assembly. Activation of WASP family
proteins activates Arp2/3 complex to create new barbed ends on existing
filaments, at a constant rate. These filaments grow rapidly and push the
membrane forward. After a short time, growth of barbed ends is terminated by
capping. Consequently the system requires continuous activation of new Arp2/3
complex, because it is consumed by incorporation into a network that grows for a
very limited time. If the rate of nucleation drops to zero, capping stops
polymerization automatically. Constitutive ATP hydrolysis within actin filaments
and dissociation of phosphate triggers severing and depolymerization at pointed
ends of actin filament by ADF/cofilin at a rate that is controlled by some of the
same signals that stimulate assembly. Nucleotide exchange catalyzed by profilin
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Figure 1.5 Dendritic nucleation model. Activation of Arp2/3 complex generates a
new F-actin branch on a pre-existing actin-filament. Rapid growth occurs at the
barbed end of actin filaments which pushes the membrane forward. Filaments
age by hydrolysis of ATP bound

to each ATP-G-actin subunit followed by

dissociation of the γ phosphate, which results in actin filaments with ADP-G-actin.
Profilin catalyzes the exchange of ADP for ATP returning subunits to the pool of
ATP-actin bound to profilin, ready to elongate barbed ends as they become
available.
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recycles ADP-actin subunits back to the ATP-actin monomer pool, and is rapidly
added to the fast growing barbed end of actin filament. Thus, in a continuously
moving lamellipodia, assembly and disassembly are balanced (Pollard et al.,
2000). If the actin depolymerization at the pointed end is slower compared to
actin polymerization at the barbed end, the pool of ATP-G-Actin will diminish thus
preventing actin polymerization and inhibiting cell migration.
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Chapter 2
Regulation of cell motility by tyrosine
phosphorylated villin1

1

Permission to reproduce by The American Society for Cell Biology.
Tomar, A., Wang, Y., Kumar, N., George, S., Ceacareanu, B., Hassid, A.,
Chapman, K.E., Aryal, A.M., Waters, C.M., and Khurana, S. (2004). Regulation
of cell motility by tyrosine phosphorylated villin. Mol. Biol. Cell 15, 4807-4817.
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2.1 Introduction
Villin, an epithelial cell-specific protein belongs to a family of actin binding
proteins that contain segments that display internal homology with each other
(Arpin et al., 1988). The amino terminal core of villin retains the actin-capping
and -severing functions of villin while the carboxyl terminal headpiece enables
villin to crosslink actin filaments. The actin modifying properties of villin are
regulated in vitro by calcium (Northrop et al., 1986a), phosphoinositides (Janmey
and Matsudaira, 1988; Kumar et al., 2004a) and tyrosine phosphorylation (Zhai
et al., 2001; Kumar and Khurana, 2004). It has been assumed for several years
that villin’s actin-bundling and not actin-severing functions are important because
unphysiologically high Ca2+ concentrations (200 µM) are required to activate
villin’s actin-severing activity. However, studies done with the villin knock-out
mice suggest that in the absence of villin, the actin-bundling properties
associated with villin can be substituted by other proteins in the microvilli (Pinson
et al., 1998); on the other hand the actin-severing activity of the microvilli is lost
(Ferrary et al., 1999). In recent years we have demonstrated that villin’s actin
modifying functions can be regulated in vitro by tyrosine phosphorylation and
PIP2, suggesting that villin has the potential to function as a link between
receptor activation and actin cytoskeleton reorganization even in the absence of
high calcium (Zhai et al., 2001; Kumar and Khurana, 2004; Kumar et al., 2004a).
In addition, we have recently demonstrated that the auto-inhibited conformation
of villin can be released by tyrosine phosphorylation of villin (as opposed to high
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Ca2+) allowing it to sever actin at physiological Ca2+ concentrations (Kumar and
Khurana, 2004). These results suggest that tyrosine phosphorylation rather than
high calcium may be the mechanism by which villin severs actin in vivo. From our
in vitro studies we developed the hypothesis that in vivo villin may be a key factor
integrating information from external stimuli that could affect the plasticity of the
actin cytoskeleton from a more rigid to a dynamic network, and that these spatial
and temporal changes in the physical properties of the cytoskeleton could
enhance cell motility (Panebra et al., 2001; Zhai et al., 2001; Kumar et al., 2004a;
Kumar et al., 2004b). Further, that villin’s ability to cycle between active
(phosphorylated) and inactive (non-phosphorylated) forms may be a critical
feature of its mechanism of action in cell migration.
The current study was designed to determine specifically the role of villin
overexpression on cell morphology and cell migration. Overexpression of other
proteins of the villin superfamily including gelsolin and CapG have been
demonstrated to increase the motile phenotypes of cells (Hartwig et al., 1989;
Aizawa et al., 1996; Chen et al., 1996; Furnish et al., 2001). Conversely, the
gelsolin-null mice and other mutant cell lines lacking these proteins have been
shown to exhibit decreased rates of cell motility (Witke et al., 1995; Lu et al.,
1997; Chellaiah et al., 2000). To confirm our hypothesis that villin and its ligandbinding activities described by in vitro experiments are mechanistically important
to villin’s relationship to cell motility, we used the villin-null HeLa cells to
overexpress villin using a tetracycline-regulated system. We demonstrate that
villin participates in actin reorganization and cell migration. Further we
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determined that tyrosine phosphorylation of villin is essential to its role in cell
migration. We have previously identified an area in the amino terminus of villin as
the site of phosphorylation. Four major sites of phosphorylation were identified in
this region by direct mutation of candidate tyrosine’s (Y) to phenylalanine (F),
namely Y-46, -60, -81, and -256 (Zhai et al., 2002). Mutation of any of these
phosphorylation sites inhibits the ability of villin protein to polymerize actin
filaments in vitro (Zhai et al., 2002). Based on our previous studies,
phosphorylated villin could regulate cell motility by modifying actin assembly by
distinct mechanisms, including lowering the binding affinity for F-actin, inhibiting
polymerization of existing actin nuclei, and/or cutting pre-existing filaments to
generate new actin nuclei (Zhai et al., 2001; Zhai et al., 2002) In this study,
we investigated the role of each tyrosine phosphorylation site of villin in actin
reorganization and cell migration by establishing HeLa cell lines stably
expressing wild-type or each of the phosphorylation site mutants (tyrosine to
phenylalanine) of villin. The ability of each mutant of villin (tyrosine to glutamic
acid) to rescue actin organization and cell migration was analyzed to confirm the
essential phosphorylation sites responsible for each of these biological
processes. We demonstrate that villin participates in actin reorganization and cell
migration by utilizing more than one phosphorylation site. We propose that villin
tyrosine phosphorylation is coordinated with actin remodeling, where it may serve
to integrate and transduce signals involved in cell migration. Since there is
significant homology between villin and other actin-capping and -severing
proteins of its family that are also tyrosine phosphorylated (De Corte et al., 1997)

27

and are known regulators of cell motility (Cunningham, 1995; Sun et al., 1995;
Arora and McCulloch, 1996), the results of our study provide a structural basis for
the mechanism of cell motility and help to understand the role of phosphorylation
in this function.

2.2 Materials
HeLa Tet-Off cells stably expressing the tTA tetracycline-controlled
transactivator

protein,

G418,

hygromycine,

doxycycline,

the

eukaryotic

expression vector pTRE-6xHN, and the selection vector pTK-Hyg were
purchased from Clonetech. Lipofectine was purchased from Invitrogen;
monoclonal antibodies to phosphotyrosine (clone PY-20) were from ICN;
monoclonal antibodies to villin were from Transduction Laboratories; hepatocyte
growth factor (HGF), epidermal growth factor (EGF), 4-amino-5-(4-chlorophenyl)7-(t-butyl)pyrazolo(3,4-d)pyrimidine

(PP2),

and

4-amino-7-phenylpyrazolo

(Forney et al., 1999) pyrimidine (PP3) were purchased from Calbiochem; Alexa
Fluor 568 Phalloidin, was acquired from Molecular Probes; fluorescein (FITC)conjugated affinity purified donkey anti-mouse IgG was purchased from Jackson
ImmunoResearch Laboratories; QuikChange site-directed mutagenesis kit was
purchased from Strategene. Src cDNA (dominant negative); (K296R/Y528F
mutation) and src monoclonal antibodies were purchased from Upstate
Biotechnology. Cell culture reagents were purchased from GIBCO-BRL (Grand
Island, NY). All other chemicals were from Sigma or Invitrogen.
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2.3 Methods
2.3.1 Villin cDNA construct. Human villin cDNA containing the entire coding
sequence cloned in the prokaryotic expression vector pGEX2T (Panebra et al.,
2001)

was

amplified

by

PCR

5’GTTCCGCGGTCGACCATGACC3’)

using
and

the

primers

GAL2

GAL1

(5’TCAATT-

GGTCTAGAACTAATA3’). These primers contain sequences for the restriction
enzymes Sal I and Xba I, respectively. The Sal I and Xba I digested amplicon
was ligated into the plasmid pTRE-6xHN that was digested with the same
restriction enzymes. The ligation reaction was used to transform XL1-Blue
competent cells and plasmids were isolated from several colonies. The plasmids
were checked by sequential double digestion with Sal I and Xba I respectively.
Plasmids that excised the insert were used for sequencing.

2.3.2 Phosphorylation site mutants of villin. Human villin cloned in the
eukaryotic expression vector pTRE-6xHN was used as a template to mutate the
known

tyrosine

phosphorylation

sites

in

human

villin.

The

identified

phosphorylatable tyrosine (Y) residues in full-length human villin were changed to
phenylalanine (F) or glutamic acid (E) by designing complementary primers.
Tyrosines at positions 46, 60, 81, and 256 were replaced with phenylalanine or
glutamic acid using the QuikChange site-directed mutagenesis kit to make
single-base changes from TAT and TAC to TTT and TTC, or GAA and GAG
respectively. The mutation primers were as follows:
Y46F, 5’- GATGGTGACTGCTTCATCATCCTGGC-3’ (forward) and
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5’-GCCAGGATGATGAAGCAGTCACCATC- 3’ (reverse);
Y60F, 5’-AGCAGCCTGTCCTTTGACATCCACTAC- 3’ (forward) and
5’-GTAGTGGATGTCAAAGGACAGGCTGCT-3’ (reverse);
Y81F, 5’-GCAGCTGCCATCTTCACCACACAGATG-3’ 4 (forward) and
5’-CATCTGTGTGGTGAAGATGGCAGCTGC- 3’ (reverse);
Y256F, 5’-TGCACTCAAACTGTTCCATGTGTCTGAC- 3’ (forward) and
5’-GTCAGACACATGGAACAGTTTGAGTGCA- 3’ (reverse).
Y46E, 5’-TCGATGGTGACTGCGAAATCATCCTGGCTATC-3’ (forward) and
5’-GATAGCCAGGATGATTTCGCAGTCACCATCGA (reverse);
Y60E, 5’-AGCAGCCTGTCCGAAGACATCCACTAC-3’ (forward) and
5’-GTAGTGGATGTCTTCGGACAGGCTGCT- 3’ (reverse);
Y81E, 5’-GCAGCTGCCATCGAAACCACACAGATG- 3’ (forward) and
5’-CATCTGTGTGGTTTCGATGGCAGCTGC- 3’ (reverse);
Y256E, 5’-TGCACTCAAACTGGAACATGTGTCTGAC-3’ (forward) and
5’-GTCAGACACATGTTCCAGTTTGAGTGCA-3’ (reverse). The introduction of
the desired codon was confirmed by sequencing.

2.3.3 Preparation of recombinant adenovirus expressing dominant negative
c-src kinase. Replication-deficient recombinant type 5 adenovirus expressing
dominant negative c-src was prepared using an adenoviral preparation kit
developed by the University of Iowa (Anderson et al., 2000). Briefly, plasmid
cDNA (containing dominant negative c-src) was digested with Hind III and Bam
HI and ligated into the pShuttle vector pacAd5 CMV K-N pA. Recombinant
homogenous virus was generated in HEK 293 cells by homologous
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recombination. Nucleotide sequencing was used to confirm the construct.
Adenoviral titers were determined by measuring their cytopathic effects in HEK
293 cells. HeLa cells were mock infected (with Ad-EGFP) or infected with the
dominant negative c-src kinase at a multiplicity of infection of 100 using standard
protocol (White et al., 1984). Cell lysates were analyzed by western blotting for csrc kinase expression.

2.3.4 Transfection of Tet-Off HeLa cells with full-length and mutant villin
cDNA. HeLa Tet-Off cells described by Gossen and Bujard (Gossen and Bujard,
1992) and stably transfected with the tTA tetracycline-controlled transactivator
were purchased from Clontech. The pTRE-6xHN full-length and mutant villin
constructs were co-transfected with a selection plasmid carrying the hygromycine
resistance gene using lipofectine. Transfected cells were selected by growing in
media containing hygromycine (400 µg/ml) and, G418 (100 µg/ml). Several
clones were obtained, all expressing villin in a doxycycline-dependent manner.
Clones expressing comparable amounts of wild-type and mutant villin proteins
were selected for further studies. For all the experiments cells transfected with
wild-type or mutant-villin proteins were grown in the absence or presence of
doxycycline (1.0 µg/ml).

2.3.5 Cell motility assay. To measure cell motility, HeLa cells transfected with
villin were seeded in 6-well plates and cultured in the absence or presence of
doxycycline. Cell migration was measured as described previously (Waters and
Savla, 1999). Briefly, confluent monolayers were scraped with a plastic pipette tip
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across the diameter of the well to produce wounds of approximately 800 µm
width. Cells were rinsed to remove cellular debris, and images were obtained at
the initial time of wounding and at various times up to 12 h post-wounding.
Images of the wounds were collected with a NikonTE300 inverted microscope
equipped with a CoolSnap FX CCD camera (Roper Scientific, Trenton, NJ), an
Optiscan ES102 motorized stage system (Prior Scientific, Rockland, MA), and a
Pentium III computer with Metamorph image analysis software (Universal
Imaging Corporation, Dowington, PA). Images were collected by programming
the X, Y, and Z coordinates of each wound location allowing the stage to return
to the precise location of the original wound. Data are expressed as a percentage
of the original wound width to normalize variability in wounding from well to well,
although similar size initial wounds were observed from experiment to
experiment. Wound width measurements were averaged from two regions of the
same well and the mean treated as a single data point. Comparisons between
mean values were made using one-way repeated-measures analysis of variance
and Turkey’s modified t test (Bonferroni criteria) with p < 0.05 considered
significant.

2.3.6 Phospho-villin antibodies. Recombinant villin that was tyrosine
phosphorylated (VILT/WT) or not (VIL/WT) was prepared as described before
(Panebra et al., 2001). A phospho-villin antibody was raised using a commercial
facility (Biosource International). One of the antibodies, clone #VP-70782 was
affinity-purified and its specificity for the phospho-epitope was examined using
western analysis. Since the villin monoclonal antibody cannot be used to
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immunoprecipitate

villin,

the

phospho-villin

antibody

was

used

to

immunoprecipitate villin from HeLa cells transfected with wild-type villin protein.
Additional immunoprecipitation studies were done with a commercially available
phospho-tyrosine antibody (clone PY-20).

2.3.7 Immunofluorescence microscopy. HeLa Tet-Off cells expressing wildtype or mutant villin proteins were cultured on coverslips and fixed in 3.7%
formaldehyde in PBS for 15 min. The slides were washed twice with phosphate
buffered saline and permeabilized by incubation in PBS containing 0.2% Triton
X-100 and 0.5% normal serum for 5 min at 4°C. The fixed and permeabilized
cells were washed three times with PBS (10 min each) and blocked with 0.1%
bovine serum albumin in TBST (20 mM Tris, pH 7.2, 150 mM NaCl and 0.1%
Tween-20) for 30 min. Cells were incubated with villin monoclonal antibody
(1:100) and Alexa Fluor 568 was included to record distribution of F-actin. The
cells were then incubated with a secondary antibody, fluorscein-5-isothiocyanate
(FITC)-conjugated affinity purified donkey anti-mouse IgG. The fluorescence was
examined by confocal laser-scanning microscopy (Zeiss LSM 5 PASCAL).

2.3.8 F-actin content measurements in HeLa cells expressing wild-type or
mutant villin proteins. The F-actin content of cells was determined as described
by Cunningham (Cunningham, 1995). Briefly, cells were fixed with 3.7%
paraformaldehyde, permeabilized with 0.5% Triton X-100, and stained with 250
nM Alexa-Phalloidin at 37°C for 30 min. Ethidium bromide-binding DNA was used
at a final concentration of 10 µM to label the DNA at room temperature for 5 min.

33

The cells were washed with PBS, scraped in 500 µl of methanol and the
fluorescence recorded. The Alexa Phalloidin was quantitated at an excitation
fluorescence recorded. The Alexa Phalloidin was quantitated at an excitation
wavelength of 578 nm and emission of 600 nm, while the DNA was measured at
excitation of 525 nm and emission of 605 nm. The relative F-actin content was
quantified as the ratio of Alexa-phalloidin fluorescence intensity to ethidium
bromide fluorescence intensity.

2.3.9 Cell proliferation measurement. Cell proliferation was measured by
bromodeoxyuridine (BrdU) labeling by quantitating BrdU incorporation into newly
synthesized DNA of replicating cells using the BrdU in-situ detection kit according
to the instructions of the manufacturer (BD PharmigenTM). Wounded monolayers
were incubated with BrdU (10 mM) for 1 h, 10 h post-wounding. The cells were
fixed, washed, permeabilized and then incubated with 0.3% H2O2 to block
endogenous peroxidase. Immuno-detection of incorporated BrdU label was done
fixed, washed, permeabilized and then incubated with 0.3% H2O2 to block
endogenous peroxidase. Immuno-detection of incorporated BrdU label was done
using a biotinylated anti-BrdU antibody that specifically recognizes 5-bromo-2’deoxyuridine showing no cross-reactivity with thymidine or uridine. BrdU
incorporation was detected by using the chromagen diaminobenzidine. Slides
were counterstained with hematoxylin.

34

2.4 Results
2.4.1 Cells expressing villin migrate faster than villin-null cells. Cells
expressing villin migrate faster than villin-null cells. HeLa Tet-Off cells were
cotransfected with full-length human villin cloned in pTRE-6xHN and pTK-Hyg
and subjected to selection with hygromycine B. Several stable transfectant lines
were expanded and screened for efficient gene induction by removal of
doxycycline. A representative transfectant of the villin gene was compared with
parental cells for the gene expression in the absence or presence of doxycycline.
western blot analysis showed that the HeLa Tet-Off cells transfected with human
villin cDNA can be induced to express significant amounts of full-length villin
protein when cultured without doxycycline, while cells cultured in the presence of
doxycycline (1.0 µg/ml) do not express villin (VIL/NULL) (figure 2.1A).
Untransfected HeLa cells as well as HeLa cells transfected with vector alone do
not express villin. A wound-healing assay was used to determine the kinetics of
migration of HeLa Tet-Off cells overexpressing villin both during basal conditions
as well as chemotactic migration. Cell migration was recorded between time 0
and 24 h post-wounding for cells transfected with wild-type villin cultured in the
presence or absence of doxycycline under low serum (1.0% fetal bovine serum)
conditions. Cell motility was judged from the reduction of the wound width 0-24 h
after the wound was made. Migration of cells expressing villin (VIL/FL) was
complete at 12 h post wounding (figure 2.1B). In contrast a significant delay in
the ability of the VIL/NULL cells (villin transfected cells cultured in the presence
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Figure 2.1 HeLa Tet-Off cells expressing wild-type villin display significantly
enhanced migration. (A) HeLa Tet-Off cells were stably transfected with fulllength human villin cDNA. Cells cultured in the absence of doxycycline express
villin (VIL/FL), whereas cells cultured in the presence of doxycycline (1.0 µg/ml)
do not express villin (VIL/NULL). Expression of villin protein was followed 0-150 h
after the addition of doxycycline. western analysis was done using monoclonal
villin antibodies. Data are representative of three experiments with similar results.
(B) Equal numbers of wild-type (VIL/FL) and villin null (VIL/NULL) cells were
cultured to confluence. Cells were denuded with a pipette tip and migration of the
remaining cells into the wound is shown 0-12 h after the wound was introduced
under low-serum condition (1.0% fetal bovine serum). Wound repair was
measured as a percentage of initial wound area. Unlike villin-null cells, cells
expressing villin seal the wound completely 12 h post wounding. Bar, 40 µm. (C)
HeLa cells expressing villin migrates faster than villin-null cells at all time points.
Migration distance was determined by taking two independent measurements
from each well in a total of 24 wells. The error bars are the measured SEM and
the asterisk denotes statistically significant values (p < 0.05, n = 24).
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of doxycycline) to migrate into the empty wound space was observed.
Assessment of cell migration revealed that wild-type villin expressing cells
exhibited a dramatic increase in cell migration compared with villin-null cells (at
12 h, four fold, n = 24, p < 0.05; figure 1B). Significant changes in the migratory
capacity of villin-expressing cells were also observed at earlier time points (figure
2.1C). Based on these data, all subsequent migration studies were done
between 0-10 h post-wounding. Untransfected HeLa cells as well as HeLa cells
transfected with vector alone migrate at the same rate in the absence or
presence of doxycycline (data not shown). Cell migration was studied at 10 h
post-wounding and in the presence of 1.0% serum, conditions that do not favor
cell proliferation. Nevertheless, DNA synthesis using 5-bromo-2’-deoxyuridine
(BrdU) immunocytochemistry was measured and showed no significant
difference in VIL/NULL and VIL/FL cells (figure A.1). These studies demonstrate
that overexpression of human villin increases cell migration. Hepatocyte growth
factor (HGF) is a multifunctional cytokine that can act as a motility inducing factor
for epithelial cells through the c-met tyrosine kinase (Sonnenberg et al., 1993).
Similarly EGF has been reported to enhance epithelial cell migration by
mechanisms varied from HGF (Singh et al., 2004) as well as comparable to HGF
(Muller et al., 2002). We measured the effects of both HGF and EGF on cell
migration. VIL/NULL and VIL/FL cells were cultured in low serum (1.0%) medium
for 24 h prior to wounding. Cells were treated with HGF (10 ng/ml) or EGF (10
nM) for 30 min and then wounded. The HGF and EGF treated cells were washed
and the media was replaced with DMEM containing 1.0% serum.
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As shown in figure 2.2, at 6 h post-wounding in the absence of any
treatment VIL/FL migrated faster than VIL/NULL cells (n = 24, p < 0.05);
treatment of these cells with HGF modestly enhanced the villin-induced cell
migration (n =24, p < 0.05). This is comparable to previous reports demonstrating
a small increase in response to HGF (Athman et al., 2003). Similarly treatment of
VIL/FL cells with EGF enhanced villin-induced cell migration by about 9% (n =24,
p < 0.01). Similar data was obtained with cells cultured overnight in the absence
of serum. Taken together these data show that expression of villin is sufficient to
enhance cell migration and that HGF and EGF can modestly augment the villininduced increase in cell migration. Further it suggests that over expression of
villin may have a direct effect on the signal transduction pathways that modify the
actin cytoskeleton and enhance cell migration.

2.4.2 Tyrosine phosphorylation of villin is essential for villin-induced cell
migration. Previous studies from our laboratory have demonstrated that villin is
a substrate in vitro for the src kinase(s) (Panebra et al., 2001; Zhai et al., 2002).
In addition our studies have suggested that villin phosphorylation and the
resulting changes in the actin rearrangements might serve to promote the
migratory phenotype of epithelial cells (Panebra et al., 2001; Zhai et al., 2002).
To confirm this, we examined the migratory capacity of cells stably expressing
wild-type villin in the absence or presence of the src kinase inhibitor PP2 and its
inactive analog PP3. In agreement with our previous results, pretreatment of
VIL/FL with the src kinase inhibitor PP2 inhibits the villin-induced cell migration.
While

PP2

inhibits

both

basal

as well
39

as EGF-induced

cell migra-

Figure 2.2 Villin-induced cell migration is enhanced by HGF and EGF. VIL/FL
cells were treated without or with HGF (10 ng/ml) or EGF (10 nM) for 30 min and
cell migration followed over a period of 6 h. Wound repair is expressed as a
percentage of the initial wound area after 6 h. VIL (-) refers to each clone
cultured in the presence of doxycycline, whereas VIL (+) refers to the same clone
cultured in the absence of doxycycline. The error bars are the measured SEM,
and the asterisk (*) and cross ( ) denote statistically significant values (p < 0.05,
n = 24, compared with VIL (-) cells) and (p < 0.05, n = 24, compared with
untreated cells) respectively.

40

tion, the effects of PP2 on villin-induced cell migration is significantly higher (11%
in VIL/NULL cells versus 20% in VIL/FL cells, n = 24, p < 0.05) (figure 2.3A).
Cells treated with the inactive analog PP3 behaved like untreated VIL/FL . A
phospho-villin antibody (VP-70782) that specifically recognizes recombinant
tyrosine phosphorylated villin (VILT/WT) and does not cross-react with
recombinant nonphosphorylated villin protein (VIL/WT) (figure 2.3B upper panel)
was used to immunoprecipitate tyrosine phosphorylated villin from HeLa cells. A
commercially available anti-phosphotyrosine antibody (PY-20) confirms the
specificity of the phospho villin antibody (figure 2.3B upper panel). The lower
panel in figure 2.3B is an SDS-PAGE of VIL/WT and VILT/WT stained with
GelCode Blue, showing the expression of the two recombinant proteins VILT/WT
and VIL/WT. Consistent with our previous studies (Panebra et al., 2001; Zhai et
al., 2002), tyrosine phosphorylation of villin (in response to wounding or
treatment with HGF/EGF) is inhibited by PP2 but not PP3 (figure 2.3C). Using
this approach, no basal tyrosine phosphorylation of villin in the absence of
wounding or EGF/HGF treatment could be detected in these cells with either
phospho-villin antibody (VP-70782) or phospho-tyrosine antibody (PY-20). Either
there is no basal phosphorylation of villin in the absence of wounding or growth
factor treatment, or there is some basal tyrosine phosphorylated villin but the
levels are too low to be detected by western analysis. These data suggest that
villin may be phosphorylated in vivo by src kinase(s) and that villin-induced
motility may be mediated by activation of src kinase(s) and tyrosine
phosphorylation of villin. To further confirm these observations, we used a
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Figure 2.3 Villin-induced cell migration is regulated by c-src kinase. (A) The Src
kinase inhibitor PP2 inhibits villin-induced cell migration. VIL/FL cells were
treated without or with the Src-kinase specific inhibitor PP2 (10 nM). The error
bars are the measured SEM, and the asterisk (*) and cross ( ) denotes
statistically significant values compared with VIL (-) cells and untreated cells (p <
0.05, n = 24) respectively. (B) Characterization of phospho-villin antibody.
Recombinant phosphorylated (VILT/WT) and nonphosphorylated (VIL/WT) villin
proteins were used to determine the specificity of the phospho-villin antibody. (C)
HeLa cells cultured in the presence or absence of doxycycline were wounded (20
wounds/dish) and allowed to migrate in the presence of HGF (10 ng/ml) with or
without the Src kinase inhibitor PP2 (10 nM) or its inactive analog PP3 (10 nM).
(D) Expression of dominant negative c-src in VIL/NULL and VIL/FL cells. This is
a western blot with c-src monoclonal antibodies. (E) Dominant negative c-src
inhibits villin-induced cell migration. VIL/FL and VIL/NULL cells were infected with
recombinant adenovirus [Ad-DN-c-src (dominant negative c-src)] for 4 h at a
multiplicity of infection of 100. This was followed by measurement of cell
migration. (F) Dominant negative c-src inhibits the tyrosine phosphorylation of
villin. Tyrosine phosphorylated villin was immunoprecipitated from VIL/FL cells
infected with or without Ad-DN-c-src by using anti-phosphotyrosine antibody
(clone PY-20), and western analysis was done using a villin mAb. This is a
representative of three experiments with similar results.
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dominant negative construct of c-src (Ad-DN-c-src). HeLa cells expressing fulllength villin cultured in the absence or presence of doxycycline were infected with
or without Ad-DN-c-src (figure 2.3D) and we measured the effect of expression of
dominant negative c-src on villin-induced cell motility. A lower band around 57
kDa was seen in these western blots and was determined to be a degradation
fragment of c-src (figure 2.3D). As shown in figure 2.3E, VIL/NULL and VIL/FL
cells infected with Ad-DN-c-src migrate at very similar rates. Thus, expression of
Ad-DN-c-src antagonized the capacity of villin to enhance cell motility, indicating
that phosphorylation of villin by c-src is required for the villin induced increase of
cell migration. Infection with an unrelated vector (Ad-EGFP) had no effect on cell
migration (figure A.2). Over-expression of Ad-DN-c-src also inhibited the tyrosine
phosphorylation levels of villin in VIL/FL cells (figure 2.3F). Ad-DN-c-src did not
completely inhibit the tyrosine phosphorylation of villin unlike PP2. One possibility
is that PP2 inhibits tyrosine phosphorylation of villin completely because PP2 can
inhibit not only c-src but also other members of the Src family including c-yes and
c-fyn, which may also be involved in the phosphorylation of villin.

2.4.3 Tyrosine phosphorylation at Y-60, Y-81, and Y-256 is essential for
villin-induced cell migration. Previous studies from our laboratory have
demonstrated that c-src phosphorylates human villin on tyrosine 46, 60, 81, and
256 (Zhai et al., 2002). To determine the role of tyrosine phosphorylated villin in
cell migration, we examined the migratory capacity of cells stably expressing
either

wild-type

or

phosphorylation

site

mutants

of

villin,

namely

VIL/Y46F,VIL/Y60F, VIL/Y81, and VIL/Y256F. Multiple clones expressing the
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villin proteins were selected by immunoblotting using villin antibodies. Clones
expressing similar amounts of villin proteins were selected for the migration
studies (figure 2.4A). We assessed the effect of overexpression of wild-type and
mutant villin proteins in HeLa Tet-Off cells on the organization of the actin
cytoskeleton. HeLa Tet-Off cells expressing wild-type and mutant-villin proteins
were stained with Alexa Phalloidin 568 (red) to examine the F-actin distribution
and the localization of villin was examined using a villin monoclonal antibody
(green) (figure 2.4B and, figure A.3). The overall morphology of HeLa cells
reconstituted with villin or with empty vector appears strikingly different.
Phalloidin staining showed that actin stress fibers were lost in villin expressing
HeLa cells (figure 2.4B, a-b). The transfection of HeLa cells with wild-type villin
results in cells that are less flat and develop membrane ruffles concurrent with
the reorganization of F-actin (figure 2.4B, b1-b3). Coincident with a virtual lack of
stress fibers in these cells is the appearance of F-actin rich membrane ruffles on
the dorsal surface and filopodia like structures, including microspikes on the
ventral surface. All of these structures contained villin. This is consistent with
previous work done by consistent with previous published reports (Friederich et
al., 1989; Franck et al., 1990). The villin and F-actin in these cells localized at the
cell perimeter where both proteins co-localized to peripheral ruffles, filopodia and
microspikes (figure 2.4B, b1-b3). These results indicate that villin can direct the
localization of F-actin to the cell cortex. The distribution of the villin mutant, Y46F,
was similar to wild-type in that greater than 90% of the villin protein as well as the
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Figure 2.4 Tyrosine phosphorylation of villin is required for villin-induced
increase in cell migration. (A) HeLa cells were stably transfected with wild-type
(VIL/FL) and phosphorylation site mutants of villin, namely, Y46F, Y60F, Y81F,
and Y256F. This figure shows representative clones of each villin construct
transfected in HeLa cells. Data are representative of six experiments with similar
results. (B) Villin expression results in reorganization of the actin cytoskeleton.
HeLa cells transfected with wild-type (VIL/FL), and mutant villin proteins were
analyzed by confocal microscopy. Double staining of villin (a1-f1) and F-actin (a2f2) was performed using villin monoclonal antibodies (1:100) and FITCconjugated anti-mouse IgG (1:200) and Alexa-Phalloidin 568 (1 µg/ml),
respectively. Composite images of villin (green) and F-actin staining (red) are
shown. Merged images (a3-f3) show colocalization of villin and F-actin. Bars, 3
µm. (C) HeLa cells expressing equal amounts of wild-type and phosphorylation
site mutants (Y to F) of villin were used in wound-healing experiments. Wound
repair is expressed as a percentage of the original wound width after 10 h. The
error bars are the measured SEM, and the asterisk (*) and cross ( ) denote
statistically significant values (p < 0.05, n = 24.). (D) Tyrosine phosphorylation of
wild-type and mutant villin proteins. Cell extracts from VIL/FL and the mutant
villin

cell

lines

VIL/Y46F,

VIL/Y60F,

VIL/Y81F,

and

VIL/Y256F

were

immunoprecipitated with phospho-villin antibody (VP-70782) and western
analysis done with villin mAb or phospho-tyrosine antibody (PY-20). This is not a
quantitative western blot. The western blot is representative of three other
experiments with similar results.
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F-actin co-localized to the cell margin (figure 2.4B, c1-c3). The morphology of
these cells was similar to VIL/FL cells with a disassembly of stress fibers and colocalization of the villin protein with F-actin in membrane ruffles, filopodia, and
microspikes. In contrast, expression of villin phosphorylation mutants Y60F,
Y81F or Y256F resulted in redistribution of F-actin, suggesting that colocalization of villin and F-actin is dependent on tyrosine phosphorylation of villin
at these sites (figure 2.4B, d-f). In all these mutant cell lines, the villin mutant
proteins were distributed diffusely in the cytoplasm as well as at the cell
periphery. In addition, the distribution of F-actin was altered and was associated
not only with the cell surface structures but also intracellularly including what
appear as dorsal arcs (figure 2.4B, e2 and f2). There was limited co-localization
of villin and F-actin at the cell margins in these cells and the majority of the villin
and F-actin remained segregated between the cell margins and the intracellular
compartment. These data suggest that phosphorylatable tyrosine residues at Y
-60, -81, and -256 are required for both the colocalization of villin with F-actin as
well as for the rearrangement of the actin cytoskeleton in the cell. Collectively,
these results suggest that expression of villin is involved in reorganization of the
actin cytoskeleton and further that villin-induced regulation of cell motility may be
dependent on this redistribution of the actin cytoskeleton. There was no change
in the total F-actin content in wild-type or mutant villin cell lines (figure A.4).
Our earlier studies including data presented in this study suggest that villin
phosphorylation and the resulting changes in the actin rearrangements in the cell
might serve to promote the migratory potential of epithelial cells. To confirm this,
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we examined the migratory capacity of cells stably expressing wild-type or
phosphorylation-site mutants of villin. As shown in figure 2.4D, wild-type villin
enhanced cell migration while the villin phosphorylation site mutants VIL/Y60F,
VIL/Y81F, and VIL/Y256F were able to completely reverse the migratory
phenotype of HeLa cells, reducing their migration rates to VIL/NULL cells. In
contrast, the villin mutant VIL/Y46F behaved like wild-type villin suggesting that
phosphorylation at this site is not essential for cell migration. To further quantify
cell migration rate, we measured cell velocity. As shown in table 2.1, the average
velocity (0.13 µm/min) of VIL/FL and VIL/Y46F shows an approximately 50%
increase in cell velocity compared with the villin-null HeLa cells 10 h postwounding (n = 24, p < 0.05). In contrast, the villin mutants VIL/Y60F, VIL/Y81F,
and VIL/Y256F moved at a lower velocity, speeds similar to the villin-null HeLa
cells (0.09 µm/min, n = 48). There was no significant difference in cell
proliferation between VIL/NULL, VIL/FL or cells expressing the phosphorylation
site mutants of villin (figure A.1). The villin protein is tyrosine phosphorylated in
all these cell lines in response to wounding. This is not a quantitative western blot
since comparison of phosphorylation levels in different cell lines with a point
mutation in one of the three phosphorylation sites could not be done with a great
deal of confidence. These data confirm that tyrosine phosphorylation of villin
regulates effective cell migration and further they characterize the specific
tyrosine residues that control this process. To confirm the role of the specific
tyrosine residues in the regulation of villin induced cell migration, we used
phosphomimetics, namely tyrosine (Y) to gluatamic acid (E) phosphorylation site
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Table 2.1 Tyrosine phosphorylation of villin regulates the rate of cell migration.

The average velocity (0.13 µm/min) of VIL/FL and VIL/Y46F shows an ~50%
increase in cell velocity compared with the villin-null HeLa cells 10 h
postwounding (n = 24, p < 0.05). In contrast, the villin mutants VIL/Y60F,
VIL/Y81F, and VIL/Y256F moved at a lower velocity, speeds similar to the villinnull HeLa cells (0.09 µm/min, n < 48). *Denotes statistically significant values (P
< 0.05, n = 24).
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mutants of villin. Multiple clones expressing the phosphomimetic villin proteins
were selected by immunoblotting using villin monoclonal antibodies. Clones
expressing comparable amounts of villin proteins were selected for the migration
studies (figure 2.5A). The intracellular distribution of villin as well as the F-actin
localization was also examined using confocal microscopy (figure 2.5B and figure
A.5). As shown in figure 2.5B, d-f, Y60E, Y81E, and Y256E look like VIL/FL. In all
these cell lines, villin and F-actin co-localize at the cell margin and in the
membrane ruffles. In contrast, VIL/Y46E resembles the VIL/NULL cells (figure
2.5B, c1-c3). As shown in figure 2.5C, VIL/Y60E, VIL/Y81E, and VIL/Y256E
migrated faster than the comparable Y to F mutants (figure 2.4C). At 10 h postwounding 95% of the wound was closed in cells expressing VIL/FL compared
with villin-null cells (65% closed). The phosphomimetics behaved like VIL/FL in
demonstrating enhanced cell migration compared with the villin-null cells, with
80-88% of the wound closed at 10 h post-wounding in VIL/Y256, VIL/Y81E, and
VIL/Y60E respectively (figure 2.5C). The rate of cell migration in VIL/Y60E,
VIL/Y81E, and VIL/Y256E was not identical to that of VIL/FL but were dosedependent and densitometric analysis revealed that they paralleled the protein
expression levels in these cell lines. The villin mutant VIL/Y46E in contrast
inhibited cell migration, migrating at the same rate as villin-null cells, suggesting
that this site must remain dephosphorylated for the motogenic effects of villin.
Together, these results indicate that efficient cell migration from wounded cell
monolayers

requires

tyrosine
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phosphorylation

of

villin.

Figure 2.5 Phosphorylation of villin at Y-60, Y-81, and Y-256 is required for villininduced cell migration. (A) HeLa cells were stably transfected with wild-type
(VIL/FL) and phosphorylation site mutants of villin, namely, Y46E, Y60E, Y81E,
and Y256E. This figure shows representative clones of each villin construct
transfected in HeLa cells. Data are representative of six experiments with similar
results. (B) Villin expression results in reorganization of the actin cytoskeleton.
HeLa cells transfected with wild-type (VIL/FL) and mutant villin proteins were
analyzed by confocal microscopy. Double staining of villin (a1-f1) and F-actin (a2f2) was performed using villin monoclonal antibodies (1:100) and FITC
conjugated anti-mouse IgG (1:200) and Alexa-Phalloidin 568 (1 µg/ml),
respectively. Composite images of villin (green) and F-actin staining (red) are
shown. Merged images show colocalization of villin and F-actin (a3-f3). Wild-type
villin and VIL/Y60E, VIL/Y81E, and VIL/Y256E colocalize with F-actin at the cell
periphery. In contrast, phosphorylation mutants of villin VIL/Y46E shows
intracellular distribution of villin and F-actin with minimal colocalization of villin
and F-actin at the cell surface. Bars, 3 µm. (C) HeLa cells expressing equal
amounts of wild-type and phosphorylation site mutants (Y to E) of villin were
used in wound-healing experiments. Wound repair is expressed as a percentage
of the original wound width at 10 h. The error bars are the measured SEM, and
the asterisk (*) and cross ( ) denote statistically significant values [p < 0.05, n =
24, compared with VIL (-) cells and p < 0.05, n = 24, compared with untreated
cells], respectively. Tyrosine phosphorylation of villin at Y60, Y81, and Y256 is a
specific mediator of villin-regulated cell migration.
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2.5 Discussion
Actin structures are dynamic and are affected by extracellular signals.
While the organization of the actin cytoskeleton in a moving cell has been
described reasonably well, it is still unclear how the cytoskeleton is directed by
external signals to coordinate its activity to provide directional movement. In the
present report we provide evidence that tyrosine phosphorylation of villin, which
could occur in response to receptor activation or during wound healing results in
both rearrangement of the microfilament structure as well as regulation of cell
migration. In this study we further demonstrated that overexpression of villin
enhances cell migration. This is consistent with previous observations made with
proteins of the villin family including cofilin (Aizawa et al., 1996), CapG, and
gelsolin (Sun et al., 1995). Data presented in our study suggest that an epithelial
cell could also use villin as an intrinsic signal to stimulate actin assembly and
increase cell migration in the absence of an external signal. Further, our studies
demonstrate that this change in cell motility by villin can be enhanced in
response to environmental cues such as chemo attractants. For our studies we
used HGF, a cytokine that is known to coordinate changes in cell morphology
associated with the induction of cell motility during epithelial-mesenchyme
transition (Boyer et al., 1996) and EGF, another powerful motogen. Together
these studies suggest that villin and other members of its family may function in
vivo to provide a signaling mechanism for translating cell surface receptor
mediated biochemical reactions into cell locomotion.
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Tyrosine kinase activity has been shown to be necessary for intestinal
epithelial cell migration (Calalb et al., 1995; Cary et al., 1996; Parsons and
Parsons, 1997; Reiske et al., 1999). Activation of c-src kinase has been reported
in pre-neoplastic colonic adenomas and in colon carcinomas. In addition
overexpression of pp60c-src has been demonstrated to increase the invasive
behavior of intestinal epithelial cells (Pories et al., 1998). Thus, both tyrosine
phosphorylation and activation of c-src kinase have been associated with the
motile properties of intestinal epithelial cells. We have previously demonstrated
that villin is phosphorylated in vitro by c-src kinase (Zhai et al., 2002). In the
present study we provide evidence that in migrating cells, villin is a substrate for
c-src kinase as well. Further, the potent and specific src kinase inhibitor PP2
inhibits the villin-induced increase in cell migration. Overexpression of the
dominant negative c-src likewise inhibits villin-induced cell migration. These data
suggest that villin is a substrate for src kinases in vivo just as it is in vitro and
furthermore that src kinase phosphorylation of villin is important for villinmediated cell motility.
We have previously identified the tyrosine phosphorylation sites in villin
and mapped phosphorylation at these sites with the actin modifying activities of
villin (Zhai et al., 2002). Human villin contain four major tyrosine phosphorylation
sites namely Y-46, -60, -81, and -256. In the current study we assessed the
effects

of

tyrosine

phosphorylation

of

villin

as

well

as

mapped

the

phosphorylation sites that regulate villin induced increase in cell migration. Our
studies revealed that phosphorylation at Y60, Y81, and Y256 are required for cell
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migration. Both Y46F and wild-type villin enhance cell migration and demonstrate
similar intracellular distribution including redistribution of actin to the cell
perimeter, loss of stress fibers and co-localization with F-actin, suggesting that
actin cytoskeletal reorganization by villin is necessary for its role in cell migration.
This is supported by the observation that the villin mutants VIL/Y60F, VIL/Y81F
and VIL/Y256F migrate like the VIL/NULL cells and demonstrate a different
subcellular distribution of villin as well as microfilament organization pattern. The
most obvious difference between villin-induced migrating and villin-null or
phosphorylation site mutant-villin cells is that villin that can be tyrosine
phosphorylated at residues 60, 81, and 256 as well as the phosphomimetics
localize at or near the cell surface. In contrast villin that cannot be tyrosine
phosphorylated at these sites, show an intracellular distribution and are not very
well distributed in cell surface structures. One possibility is that by altering the
ability of villin to be tyrosine phosphorylated, we may have modified the ligandbinding properties of villin that determine its intracellular distribution and
localization.
Recombinant tyrosine phosphorylated villin does not associate with PIP2,
while non-phosphorylated villin does (Panebra et al., 2001). Further, we have
demonstrated that tyrosine phosphorylation of villin decreases villin’s binding
affinity for F-actin (Zhai et al., 2001). This would suggest that within the cell at or
near the leading edge, there could be two separate pools of villin, tyrosine
phosphorylated villin that does not associate with the plasma membrane and has
decreased affinity for F-actin and nonphosphorylated villin, which could bind both
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PIP2, and F-actin. Consistent with this observation we have previously reported
that tyrosine phosphorylated villin redistributes to a Triton X-100-soluble fraction
of intestinal villus cells, while non-phosphorylated villin remains associated with
the F-actin filaments in a Triton-insoluble fraction (Khurana et al., 1997). Since
phosphorylated villin does not associate with PIP2, we speculate that this Tritonsoluble pool may represent the cellular G-actin pool while the Triton X-100
insoluble pool is the F-actin pool in live cells. This is a reasonable speculation
since we have also reported that tyrosine phosphorylation of villin releases an
auto-inhibited conformation allowing it to sever actin filaments at physiological
Ca2+ concentrations (Kumar and Khurana, 2004). Further, we have identified the
biochemical properties of the individual phosphorylation sites in villin.
Phosphorylation at Y60 enhances the actin-severing activity of villin, suggesting
that this site could be involved in generating new barbed ends (Zhai et al., 2002).
In contrast, phosphorylation at Y81 and Y256 inhibits the ability of villin to
polymerize actin filaments, thus altering the F-actin dynamics in vivo. These sites
may have additional biochemical properties such as to decrease the binding
affinity of villin for F-actin, decrease the actin-crosslinking activity of villin and/or
induce conformational changes in villin resulting in constitutively-active villin that
can sever actin filaments at nanomolar Ca2+. We have previously shown all these
functions of villin to be regulated by tyrosine phosphorylation (Zhai et al., 2001;
Kumar and Khurana, 2004). Alternatively, in vivo these tyrosine phosphorylation
sites may be ligand-binding sites for second messengers that may regulate either
tyrosine phosphorylation of villin such as c-src kinase or yet unidentified tyrosine
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phosphatases, as well as the SH2 domain of PLC-γ1 (Panebra et al., 2001), all of
which would modify villin-induced cell migration.
The integrity of these tyrosine residues is required for actin-nucleation and
-depolymerization by villin, since phosphorylation of any one site impairs villin’s
capacity to nucleate actin, and likewise mutation at Y60 to F severely impairs
phosphorylated villin’s ability to sever actin filaments (Zhai et al., 2002). In other
words, villin’s ability to regulate the actin dynamics is dependent on its
phosphorylation. Inhibition of cell migration by villin mutants suggests that a
decrease in the actin-severing activity of villin is a negative regulator of villininduced

increase

in

cell

migration.

In

other

words,

increased

actin

depolymerization by villin could be the signal for the enhanced cell migration. The
phosphomimetics lend further support to the idea that phosphorylation of villin at
these three sites is necessary for the regulation of villin-induced migration.
Interestingly the villin mutant Y46E inhibited cell migration. The significance of
this observation is not clear at this point except it suggests that while
phosphorylation at Y46 is not required for cell migration (VIL/Y46F behaves like
VIL/FL), maintaining this site in a dephosphorylated form may be necessary for
the villin-induced effects on cell migration. This also suggests that regulation of
cell migration by villin may require both kinases and phosphatases maintaining
the Y-60, -81 and -256 sites in a phosphorylated state and the Y46 site in a
dephosphorylated state for efficient cell migration. Based on our observations we
propose the following model for villin-induced cell migration. We believe that
spatially restricted accumulation of signaling molecules could determine the
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activation of one or more of villin’s actin-regulatory properties, thus establishing
villin’s function in regulating cell motility. One of these signals could be a tyrosine
kinase and/or phosphatase that could determine the phosphorylation state of
villin. In the unphosphorylated state the actin-crosslinking property of villin could
be important. For instance it is known that crosslinking of actin filaments is
essential to convert the force of polymerization into forward movement of the
membrane and the cell. While Arp 2/3 is considered the major crosslinking
component it is possible that in epithelial cells villin plays a significant role in
crosslinking the actin filaments and generating stable lamellae. The crosslinking
functions of villin could determine the rate and extent of lamellipodia formation
and/or regulate the amount of F-actin incorporated into newly formed
lamellipodia. Unphosphorylated villin could also bind the membrane phospholipid
PIP2 and the villin-PIP2 complex could favor persistent growth of the barbed ends
by preventing capping of the barbed ends thus favoring both filament growth as
well as allowing actin to push the membrane forward.
Phosphorylated villin could have other functions. Phosphorylation of villin
could increase actin depolymerization, which could replenish the actin monomer
pool thus allowing the cell to maintain high concentration of unpolymerized actin
far from the equilibrium. Depolymerization of actin by villin could also produce
new barbed ends that may be used for the formation of new filaments.
Phosphorylation of villin and activation of villin’s actin-capping function could help
cap barbed ends. Capping of barbed ends could help maintain the length of actin
filaments thus resulting in short filaments that can generate propulsive force and
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effectively push the membrane forward. Tyrosine phosphorylation of villin could
regulate directed cell movement. It is possible that some of the phosphorylation
site mutants exhibit lower migration rates because of lack of directed and
coordinated movement. Since phosphorylated villin also disassembles actin
filament bundles, cytoskeletal disassembly associated with disruption of actin
bundles by tyrosine phosphorylated villin could generate pulling forces that may
even be involved in the rearward retraction of a moving cell. Examples of such
solationcontraction include microtubules that segregate chromosomes during
mitosis (Mogilner and Oster, 2003), and sperm of the nematode Ascaris suum
(Miao et al., 2003). Cell migration is intimately linked to cytoskeleton dynamics
and our study demonstrates that tyrosine phosphorylation which affects
cytoskeleton dynamics also affects cell migration. Our studies suggest that
filament turnover in cells may be defined by the regulated action of actin-binding
proteins interacting with signaling molecules.
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Chapter 3
Interaction of phospholipase C- γ1 with villin
regulates epithelial cell migration2

2

Permission to reproduce by The American Society for Biochemistry and
Molecular Biology. Tomar, A., George, S., Kansal, P., Wang, Y., and Khurana, S.
(2006). Interaction of phospholipase C-γ1 with villin regulates epithelial cell
migration. J. Biol. Chem. 281, 31972-31986.
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3.1 Introduction
In intestinal epithelial cells as well as in the opossum kidney cell line,
tyrosine phosphorylation of villin regulates ion transport (Khurana et al., 1997;
Papakonstanti et al., 2000).

In addition, rearrangement of the microvillar

cytoskeleton and concomitant redistribution of villin have been reported in studies
with enteroinvasive bacteria (Finlay and Cossart, 1997), in intestinal restitution
(Nusrat et al., 1992; Albers et al., 1996), in renal ischemia, ischemia of the small
intestine (Barthod, 1994; Golenhofen et al., 1995; Brown et al., 1997; White et
al., 2000) as well as in colonic adenocarcinomas (Bacchi and Gown, 1991). It
may be noted that villin expression is maintained in carcinomas derived from
renal and intestinal epithelial cells.

Villin is also expressed in other

adenocarcinomas even though it is absent from normal tissue such as in
Barrett’s metaplasia and gastric cardia adenocarcinomas. More recently, chronic
Helicobacter pylori infection has been shown to induce endogenous villin
expression in the stomach (Rieder et al., 2005). Consistent with this and other
studies, it has been suggested that villin expression arises in these tissues in
response to chronic injury and may be a marker of pre-neoplastic lesions and
may even participate in the altered genetic program that results in intestinal
metaplasia (Tsukamoto et al., 2004). Studies done with the villin knock out mice
show that villin is required for intestinal cell migration as well as Shigella infection
(Athman et al., 2003; Athman et al., 2005). Abnormalities in villin gene
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expression have also been associated with progressive cholestatic liver disease
(Phillips et al., 2003).
Villin is a member of a conserved family of actin-associated proteins
widely expressed from slime molds to humans.

Severin from Dictyostelium

discoideum, fragmin from Physarum polycephalum and the vertebrate proteins
villin, gelsolin, adseverin and scinderin belong to the group of actin-severing
proteins that contain 3-6 repeats of a conserved domain. Villin contains six such
domains (S1-S6). Like several proteins of its family, villin caps, nucleates and
severs actin filaments and these functions are confined to the villin core (S1-S6).
Villin contains in addition, a carboxyl-terminal domain (S7) called the headpiece,
which provides villin with the ability to crosslink actin filaments (Glenney and
Weber, 1981). We have previously demonstrated that villin is tyrosine
phosphorylated in vitro and in vivo by c-src kinase (Panebra et al., 2001; Tomar
et al., 2004; Wang et al., Submitted). Likewise, gelsolin, fragmin and CapG have
been shown to be tyrosine phosphorylated in vitro by c-src (De Corte et al.,
1997). Further, proteomic analysis of phosphotyrosyl-proteins in human lumbar
cerebrospinal fluid has been shown to include tyrosine phosphorylated gelsolin
(Yuan and Desiderio, 2003). These reports and our own data point to a more
general mechanism involving tyrosine phosphorylation of this family of proteins.
Thus, giving new properties to these proteins and adding another level of
regulation that will be recognized by future studies involving the identification of
the phosphorylated tyrosine residues and functional assays. Epithelial cells of
the intestine and kidney express more than one protein of this family (villin,
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gelsolin and adseverin) (Lueck et al., 1998). We and others have previously
reported that while these proteins share structural homology they are not
functionally identical (Finidori et al., 1992; Panebra et al., 2001; Kumar and
Khurana, 2004; Kumar et al., 2004a; Kumar et al., 2004b). The identification of
the tyrosine phosphorylation sites and their molecular characterization in these
proteins will facilitate our understanding of their functional diversity.

Further,

such studies will help elucidate why some cells express more than one protein of
this family and whether these proteins have identical, overlapping or distinct
functions in these tissues.
Tyrosine phosphorylation of villin releases its autoinhibited conformation
allowing it to sever actin at physiologically relevant calcium concentrations
(Kumar and Khurana, 2004).

We have also reported that tyrosine

phosphorylation regulates villin functions, specifically, villin’s ability to modify the
actin cytoskeleton, redistribution of F-actin in cells as well as villin-induced
changes in cell shape and cell motility (Tomar et al., 2004). In addition, tyrosine
phosphorylation of villin modifies villin’s ligand-binding properties, including its
association with phosphatidylinositol 4,5-bisphosphate (PIP2), phospholipase Cγ1 (PLC-γ1) and F-actin (Khurana et al., 1997; Panebra et al., 2001; Zhai et al.,
2001). Regulation of villin’s functions by tyrosine phosphorylation, which is often
a consequence of receptor activation, suggests that villin may function to
communicate cell surface activation to the cytoskeletal machinery.
In an effort to comprehend the role of tyrosine phosphorylation to villin’s
function, we have elected to identify the tyrosine phosphorylation sites in human
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villin and map villin’s functions to these sites. We have previously identified four
major phosphorylated tyrosine residues in the villin core (Zhai et al., 2002; Tomar
et al., 2004). In the present study we identify six additional sites in the carboxylterminal villin core (domains S3-S6). With this study we have identified all the
tyrosine residues in human villin that can be phosphorylated and mapped the
functions of villin regulated by these phosphorylation sites. Specifically, we have
characterized the role of these sites in regulating F-actin reorganization, cell
morphology

and

cell

motility

by

transfecting

full-length,

truncation

or

phosphorylation site mutants of villin in the tetracycline regulated HeLa and
MDCK cells. In this report, we demonstrate for the first time that the carboxylterminal tyrosine phosphorylation sites in villin are required for its association
with PLC-γ1, thus determining their significance in villin-induced cell migration.
Since there is considerable structural and functional homology between villin and
other proteins of its family, the results presented herein help understand the
relationship of phosphorylation with the role of these proteins in cell migration
(Arpin et al., 1988; Arora and McCulloch, 1996; Folger et al., 1999; Athman et al.,
2003; Tomar et al., 2004).

3.2 Materials
Epicurian coli TKX1 and BL21 competent cells and the Quick-Change sitedirected mutagenesis kit were from Stratagene.
Fastflow was from Amersham-Pharmacia.

Glutathione Sepharose 4B

GelCode Blue was from Pierce.

Monoclonal antibodies to phosphotyrosine (clone PY-20) were from ICN;
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monoclonal antibodies to villin were from Transduction Laboratories and,
polyclonal phospho-villin antibody VP-70782 used in these studies has been
described previously (Tomar et al., 2004).

Monoclonal antibodies to

phospholipase C-γ1 were purchased from Upstate Biotechnology. Monoclonal
antibody to the influenza A virus haemagglutinin (HA) tag was purchased from
Roche. Alexa Fluor 488-phalloidin was purchased from Molecular Probes; and
Cy3-conjugated affinity purified donkey anti-mouse IgG was purchased from
Jackson ImmunoResearch Laboratories.

Lysophosphatidic acid (LPA) and

epidermal growth factor (EGF) were purchased from Sigma-Aldrich. In situ Cell
Death Detection kit, POD was purchased from Roche. HOECHST 33258 was
purchased from Sigma-Aldrich. HeLa Tet-Off cells stably expressing the tTA
tetracycline-controlled

transactivator,

G418,

hygromycin,

doxycycline,

the

eukaryotic expression vectors pTRE-6 x HN, pTRE-HA and the selection vector
pTK-Hyg were purchased from BD Biosciences Clonetech. MDCK Tet-Off cells
were a kind gift from Dr. Keith Mostov (UCSF, California). LipofectamineTM 2000
was purchased from Invitrogen Laboratories. 35 mm glass bottom culture dishes
were purchased from Mat Tek Corporation. The muscle actin polymerization kit
was purchased from Cytoskeleton (Denver, CO). All other chemicals were from
Sigma or Invitrogen. Monoclonal antibodies to phospholipase C-γ1 were
purchased from Upstate Biotechnology. Monoclonal antibody to the influenza A
virus haemagglutinin (HA) tag was purchased from Roche. Alexa Fluor 488phalloidin was purchased from Molecular Probes; and Cy3-conjugated affinity
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purified donkey anti-mouse IgG was purchased from Jackson ImmunoResearch
Laboratories.

3.3 Methods
3.3.1 Tyrosine phosphorylation of villin in TKX1 cells. Full-length or mutant
villin cDNA cloned in pGEX-4T1 were expressed in E. coli TKX1 cells as
described previously (Panebra et al., 2001). Briefly, TKX1 cells carry a plasmid
with the elk tyrosine kinase (tk) gene controlled by the trp promoter. The TKX1
cells were transformed with wild-type or mutant villin plasmids.

A two-step

protocol was followed to first induce the villin gene (by addition of isopropy-γ-Dthiogalactropyranosie (IPTG)) followed by induction of the tk gene (by addition of
indoleacrylic acid (IAA)), which generated glutathione S-transferase (Gst)-tagged
tyrosine-phosphorylated villin protein(s). TKX1 cells transformed with the villin
gene and cultured in the absence of IAA were used to obtain non-phosphorylated
villin controls.

Tyrosine phosphorylated proteins were detected by western

analysis using a phosphotyrosine monoclonal antibody (PY-20). Densitometric
analysis was carried out using Scion Image software.

3.3.2 Amino-terminal truncation mutants of villin.

To identify the villin

phosphorylation site(s) we created amino-terminal truncation mutants of villin
using full-length human villin cDNA cloned in the prokaryotic expression vector
pGEX-4T1.

Briefly, polymerase chain reaction was used to introduce EcoRI
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(Forward) and XhoI (Reverse) restriction sites using the following primers: CT,
5’ (Forward)-AGGGAATTCGCCACACGGCCACTGACA,
5’ (Reverse)-CTTTCTCGAGGAAT-AGGTACATTATTA;
CT1, 5’ (Forward)-GTGGAATTCGTGAAGTTCGATGCCACA,
5’(Reverse)-CTTTCTCGAGGAAT-AGGTACATTATTA;
CT2,5’ (Forward)-TTTGAATTCCCAGCGCGGGCCAATTTC,
5’(Reverse)- CTTTCTCGAGGAATAG-GTACATTATTA;
CT3, 5’(Forward)- AGGGAATTCGCCACACGGCCACTGACA,
5’(Reverse)- TTTGGCCCTCGAGC-CCACAGTGTG;
CT4, 5’(Forward)- GTGGAATTCGTGAAGTTCGATGCCACA,
5’ (Reverse)-TGGACCTCGAGCAGC-CGTGTGGAG.
The PCR amplicons were digested using EcoRI and XhoI and directionally
cloned in pGEX-4T1. The cloning of the specific truncation mutants were
confirmed by sequencing.

3.3.3 Substitution of tyrosine with phenylalanine in villin truncation
mutants. The putative phosphoryable tyrosine (Y) residues in the truncation
mutants

(CT2-CT6)

were

changed

to

phenylalanine

(F)

by

designing

complementary primers in which a Y codon was replaced with an F codon.
Tyrosine’s at positions 286, 296, 324, 422, 427, 431, 433, 441, 444, 461, 470,
555, 604, 681, 725 were replaced with phenylalanine using the QuikChange sitedirected mutagenesis kit to make single-base change from TAT and TAC to TTT
and TTC respectively.

The mutation primers were as follows: Y286F,

5’(Forward)-TCACGAGGACTGGTTTCA-TCCTGGACCAGG and 5’ (Reverse)68

CCTGGTCCAGGATGAAACAGTCCTCGTGA; Y296F, 5’ (Forward)-GGCCTGAAGATCTTCGTGTGGAAAGGG and
5’ (Reverse)-CCCTTTCCACACGAACATC-TTCAGGCC;
Y324F, 5’ (Forward)-ATCAAAGCCAAGCAGTTCCCACCAAGCACACCAG and
5’ (Reverse)-CTGTGTG-CTTGGTGGGAACTGCTTGGCTTTGAT;
Y422F 5’ (Forward)-CTAGGCCACTTC-TTTGGGGGCGACTGC and
5’ (Reverse)-GCAGTCGCCCCCAAAGAAGTGGCCT-AG;
Y427F, 5’ (Forward)-GGGGGCGAC-TGCTTCCTGCTGCTCTAC and
5’ (Reverse)-GTAGAGCAGCAGGAAGCA-GCAGTCGCCCCC;
Y431F, 5’ (Forward)-TACCTGCTGCTCTTCACCTACCTCATC and
5’ (Reverse)-GATGAGGTAGGTGA-AGAGCAGCAGGTA;
Y433F, 5’ (Forward)-CTGCTCTACACCTTCCTCA-TCGGCGAG and
5’ (Reverse)-CTCG-CCGATGAGGAAGGTGTAGAGCAG;
Y441F, 5’(Forward)-GGCGAGAAGCA-GCATTTCCTGCTCTACGTTTGG and
5’ (Reverse)-CCAAACGTAGAGCAGGAA-ATGCT-GCTTCTCGCC;
Y444F, 5’ (Forward)-CATTACCTGCTCTTCGTTTG-GCAGGGC and
5’ (Reverse)-GCCCTGC-CAAACGAAGAGCAGGTAATG;
Y461F 5’ (Forward)-ACAGCATCAGCTTTCA-AGCCGTCATC and
5’ (Reverse)-GATGACGGCTTGAAAAGCTGATGCTGT;
Y470F,5’(Forward)-CCTGGACATCCGGACCAGAAGTTCAATGGTGA and
5’(Reverse)-GACTGGTT-CACCATTGAACTTCTGGTCCAGGAT;
Y555F, 5’ (Forward)-ACCCAGTCTTGCT-GCTTTCTATGGTGTGGGAAG and
5’ (Reverse)-CTTCCCACACCATAGAAA-GCAGCAAGACTGGGT;
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Y604F, 5’ (Forward)-TGGGAAGGCCCCCTTTGCC-AACACCAAGAG and
5’ (Reverse)-CTCTTGGTGTTGGCAAAGGGGGCCTTCCCAC;
Y681F, 5’ (Forward)-ACCACTG-CACAGGAATTCCTCAAGACCCATCCC and
5’ (Reverse)-GGGATGGGTCTTGA-GGAATTCCTGTGCAGTGGT;
Y725F, 5’ (Forward)-TAACACCAAATCCTTTGA-GGACCTGAAGG and
5’ (Reverse)-CCTT-CAGGTCCTCAAAGGATTTGGTGTTA.

A villin mutant

lacking all ten identified tyrosine phosphorylation sites namely Y-46, -60, -81,
-256, -286 , -324, -461, -555, -604 and -725 (substituted with phenylalanine) was
made to confirm the tyrosine phosphorylation status of recombinant villin
expressed in TKX1 cells (VILT/WT (AYFM)).

3.3.4 Urea denaturation assay. To determine the effects of specific mutations
on the overall stability of the villin molecules, fluorescence-monitored urea
denaturation was performed on each recombinant protein as described
previously (Kumar et al., 2004b). Fluorescence measurements were taken at an
excitation wavelength of 280 nm and at an emission scan was performed from
335 nm to 360 nm.

3.3.5 Measurement of actin-polymerization and -depolymerization by
phosphorylated wild-type and point mutants of villin. The kinetics of actinpolymerization were determined using a muscle actin polymerization kit
according to the instructions of the manufacturer and as described previously
(Kumar et al., 2004a).

The ability of villin to nucleate actin assembly or to

depolymerize actin filaments was determined by its effect on the rate and extent
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of increase or decrease, respectively, of fluorescence of pyrene-labeled actin.
Fluorescence measurements were performed at 25oC using the FluoroMax 3
spectrofluorometer.

The excitation wavelength was set at 365 nm, and the

emission wavelength was set at 407 nm.

3.3.6 Measurement of actin uncapping by phosphorylated wild-type and
point mutants of villin. The actin-capping activity of wild-type and mutant villin
proteins was measured essentially as described by Northrop et al using pyrenelabeled actin as described by Schafer et al (Northrop et al., 1986b; Schafer et al.,
1996).

290 nM villin-actin seed were used as nuclei for polymerization with

pyrene-labeled G-actin (1.4 µM) in a reaction volume of 200 µl. The increase in
fluorescence was measured over time as described before (Kumar et al., 2004a).
The concentration of calcium (2.5 µM) used in the assays has been shown to be
saturating for capping but not severing of actin filaments by villin.

3.3.7 Transfection of HeLa and MDCK Tet-Off cells with full-length and
mutant villin cDNA. Full-length villin and the point mutants of villin (Y286F;
Y324F; Y461F; Y555F; Y604F and Y725F were cloned in the eukaryotic
expression vector pTRE-6 x HN by amplification using polymerase chain reaction
of the coding sequences cloned in pGEX-4T1 as described before (Tomar et al.,
2004). Three additional constructs were made: (i) VIL/ANFM, in which all four
amino-terminal tyrosine phosphorylation sites, namely Y46, Y60, Y81 and Y256,
were mutated to phenylalanine; (ii) VIL/ACFM, in which all six carboxyl-terminal
tyrosine phosphorylation sites, namely Y286, Y324, Y461, Y555, Y604 and Y725
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were mutated to phenylalanine and

(iii)VIL/AYFM, in which all ten

phosphoryable tyrosine residues were mutated to phenylalanine. Yellow
fluorescent protein tagged version of full-length villin was made by using
superenhanced yellow fluorescent protein (SEYFP) subcloned into the Sal 1 site
of full-length villin cloned into pTRE-HA

between the HA tag and villin

(SEYFP/FL) in collaboration with Dr. Ian Macara (University of Virginia School of
Medicine, Charlottesville, VA) (Tomar et al., 2004). To check if villin and SEYFP
were

in

frame

the

following

primer

was

used,

5’-CATGGTCCTGC-

TGGAGTTCGTCA; and to check if SEYFP was in frame with the HA tag, the
following sequencing primer was used, 5’-CGC-CTCCAGACGCCATCCACGCT.
Deletion mutant S1-S3 (SEYFP/S1-S3) was made by designing complementary
primers to introduce a stop codon at positions 338 of SEYFP/VIL using the
QuikChange

site-directed

mutagenesis

kit,

as

recommended

by

the

manufacturer. The introduction of the stop codon was verified by sequencing.
SEYFP tagged versions of VIL/ANFM, VIL/ACFM and VIL/AYFM were cloned by
digesting VIL/ANFM, VIL/ACFM and VIL/AYFM cloned in pTRE-HA with Sal I.
Likewise the 0.7 kb SEYFP fragment was obtained by digestion of SEYPF/FL
with Sal I. The recombinant constructs VIL/ANFM, VIL/ACFM or VIL/AYFM were
ligated with the SEYFP fragment using non-directional sticky end cloning. The
cloning of the SEYFP insert was verified by sequencing and the SEYFP fragment
was found upstream of VIL/ANFM, VIL/ACFM as well as VIL/AYFM sequence
and in correct reading frame with the HA tag. HeLa Tet-Off cells were stably cotransfected with the wild-type or mutant villin plasmids and a selection plasmid
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carrying the hygromycin resistance gene. Villin-null HeLa and MDCK Tet-Off
cells were transiently transfected with SEYFP/FL, SEYFP/ACFM or SEYFP/S1S3 plasmids and cells were analyzed 16-24 h post-transfection. Alternatively,
MDCK Tet-Off cells were stably transfected with SEYFP/FL, SEYFP/ANFM,
SEYPF/ACFM or SEYFP/AYFM.

3.3.8 Cell motility assay.

HeLa Tet-Off cells transfected with wild-type or

mutant villin proteins were seeded in six-well plates and cultured in the absence
(VIL +) or presence (VIL -) of doxycycline. Confluent monolayers were scraped
with a plastic pipette tip to generate wounds essentially as described before
(Tomar et al., 2004). Images were obtained at the initial time of wounding and at
various time intervals up to 24 h post-wounding.

Data are expressed as a

percentage of original wound width. Wound width measurements were averaged
from two regions of the same well and the mean treated as a single data point.
Comparisons between mean values were made using one-way repeatedmeasures analysis of variance and Tukey’s modified t test (Benferroni criteria)
with p < 0.05.

3.3.9 Immunofluorescence microscopy. HeLa Tet-Off cells expressing wildtype and mutant villin proteins were cultured on coverslips and fixed in 3.7%
formaldehyde and permeabilized by incubation in phosphate buffered saline
containing 0.2% Triton X-100 and 0.5% normal goat serum.

Cells were

incubated with villin monoclonal antibody (1:100) and Alexa Fluor 488-phalloidin
was included to record the distribution of F-actin. The secondary antibody was
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Cy3-conjugated affinity purified donkey anti-mouse IgG (1:100).

The

fluorescence was examined by confocal laser scanning microscopy (LSM 5
PASCAL; Carl Zeiss, Thornwood, NY).
For time-lapse microscopy, cells were incubated on 35-mm glass bottom
dishes. MDCK/HeLa cells transiently transfected with SEYFP/FL or SEYFP/S1S3 were used for these studies, 16-24 h post-transfection. Alternatively MDCK
Tet-Off cells stably transfected with SEYPF/FL, SEYFP/ANFM or SEYFP/ACFM
were used for these studies. Cells were washed twice with phosphate-buffered
saline and 50 ng/ml of epidermal growth factor (EGF) or lysophosphatidic acid
(LPA 1 µM) were added to the cells 5 min before time lapse images were
captured. Time lapse images were acquired with a 40 x objective on a confocal
microscope (LSM 5 PASCAL, Carl Zeiss, and Thornwood, NY). Images were
captured every 2 min for a maximum of 60 minutes.

3.3.10 Measurement of lamellipodial protrusion rate.

Lamellipodia were

characterized as thin regions 3-10 microns wide located at the cell margin. Using
time lapse imaging, lamellipodia protrusion rate was measured as the increase in
total cell area after growth factor (LPA (1 µM) or EGF (50 ng/ml)) stimulated cell
migration using time lapse images essentially as described before (Rottner et al.,
1999; Athman et al., 2003). The mean relative area was plotted as a function of
time to measure rate of protrusive activity after EGF/LPA treatment.
Approximately 10 cells were examined and for all cells the rate remained
approximately constant during the 20 minutes of observation.
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3.3.11 Immunoprecipitation and western blot analysis. HeLa or MDCK TetOff cells transfected with full-length villin (VIL/FL) or phosphorylation site mutants
of villin namely, VIL/ACFM or VIL/AYFM were extracted with a solution
containing 1% Triton X-100, 20 mM HEPES, pH 7.2, 150 mM NaCl, 1 mM
sodium orthovanadate, 50 mM NaF and a cocktail of protease inhibitors for 15
min at 4oC.

PLC-γ1 were immunoprecipitated from the soluble extracts as

described previously (Khurana et al., 1997) by using monoclonal antibodies to
PLC-γ1. Tyrosine phosphorylated proteins were Immunoprecipitated from MDCK
Tet-Off cells lysed using modified RIPA buffer containing 50mM Tris-HCl pH 7.4,
1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF,
Aprotinin, leupeptin, pepstatin 1 µg/ml each, 1 mM Na3VO4, and 1 mM NaF for
15 min at 4oC. Immunoprecipitated proteins were separated by SDS-PAGE,
transferred to nitrocellulose membrane and western analysis done with villin
monoclonal antibodies.

3.3.12 Separation of Triton-soluble and -insoluble pool. For fractionation of
Triton X-100 -soluble and -insoluble pool, MDCK Tet-Off cells expressing VIL/FL,
VIL/ACFM or VIL/AYFM were lysed in buffer containing 1% Triton X-100, 20 mM
HEPES, pH 7.2, 150 mM NaCl, 2 mM EDTA, 1 mM sodium othovanadate, 50
mM NaF and a cocktail of protease inhibitors for 15 min at 4oC.

After

centrifugation, supernatants were collected and represented the Triton-soluble
pool. The pellets were resuspended in buffer containing 15 mM HEPES, pH 7.5,
150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mM
EDTA, 1 mM dithiothreitol, 1 mM sodium orthovanadate and a cocktail of
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protease inhibitors. Samples were vortexed well and incubated on ice for 20 min
on ice.

The pellet fraction was centrifuged and the resulting supernatant

represented the Triton-insoluble pool. Triton-soluble and -insoluble proteins were
separated by SDS-PAGE, transferred to nitrocellulose membrane and western
analysis done with villin monoclonal antibodies.

3.3.13 Identification of apoptotic cells using HOECHST 33258 staining.
MDCK Tet-Off cells transiently transfected with SEYFP-tagged S1-S3 villin
truncation were incubated with HOECHST 33258 16 h post-transfection at a
concentration of 20 µg/ml for 10 min at room temperature. Apoptotic cells were
distinguished from viable cells by nuclear condensation and DNA fragmentation
seen as bright blue fluorescence in the nuclei.

Morphological changes

corresponding to non-viable cells were determined using an inverted Nikon
fluorescence microscope with a CoolSnap FX charge coupled device camera.

3.4 Results
3.4.1 The carboxy-terminus of villin is tyrosine phosphorylated. We have
previously identified four major tyrosine phosphorylation sites (Y-46, -60, -81 and
-256) in the amino terminus of villin (Zhai et al., 2002). Substitution of all four of
these sites with phenylalanine allowed us to determine that there were additional
phosphorylation sites in the carboxy terminus of villin that were tyrosine
phosphorylated in vitro (figure 3.1A). Likewise, expression of this amino-terminal
phosphorylation site mutant of villin (VIL/ANFM) in MDCK Tet-Off cells allowed
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Figure 3.1 Tyrosine phosphorylation of wild-type and truncation mutants of villin.
(A) Carboxy terminus of villin contains additional tyrosine phosphorylation sites.
Four of the tyrosine phosphorylation sites identified in previous studies (Y-46,
-60, -81 and -256) were mutated to phenylalanine (ANFM) (Zhai et al., 2002).
The mutant villin protein cloned in the pGEX-4T1 was expressed as a nonphosphorylated protein (VIL/WT (ANFM)) by expression in TKX1 cells in the
absence of IAA (see Materials and Methods) or as a phosphorylated protein by
expression in TKX1 cells in the presence of IAA (VILT/WT (ANFM)). (B) Aminoterminal phosphorylation site mutant of villin is tyrosine phosphorylated in MDCK
Tet-Off cells. Cell extracts from MDCK Tet-Off cells stably transfected with fulllength villin (VIL/FL) or amino-terminal phosphorylation site mutant (VIL/ANFM)
were immunoprecipitated with phospho-villin antibody (VP-70782) described
previously (Tomar et al., 2004) and western analysis done with phospho-tyrosine
antibody. (C) Schematic representation of wild-type and amino-terminal
truncation mutants of villin that were expressed as Gst-tagged phosphoryable
proteins in TKX1 cells. (D) Expression and tyrosine phosphorylation of wild-type
(VILT/WT) and truncation mutant (CT-CT4) villin proteins. The left panel is an
SDS-PAGE analysis of recombinant, phosphorylated wild-type (VILT/WT) and
amino-terminal truncation mutants of villin. The gels were stained with GelCode
Blue. The right panel is a western blot of VILT/WT and truncation mutants of
villin probed with phosphotyrosine monoclonal antibody (PY-20).
representative of four experiments with similar results.
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Data are
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us to confirm our observation that there were additional phosphorylation sites in
the carboxyl terminal domain of villin (figure 3.1 B). For these studies, cell
extracts of MDCK Tet-Off cells expressing wild-type villin (VIL/FL) or the aminoterminal

phosphorylation

site

mutant

of

villin

(VIL/ANFM)

were

immunoprecipitated with a phospho-villin antibody (VP-70782) and probed with a
phospho-tyrosine antibody (PY-20) essentially as described before (Tomar et al.,
2004). Together these studies demonstrate that both in vitro as well as in MDCK
cells, the carboxyl terminal domain of villin contribute to the tyrosine
phosphorylation of villin.
phosphorylation

sites

In addition, the identification of at least five tyrosine
in

human

plasma

gelsolin

including

a

major

phosphorylation site in domain S4, led us to speculate that villin may, likewise,
have tyrosine phosphorylated residues in the carboxyl-terminal domain(s) (De
Corte et al., 1999). To identify these sites in villin as well as to determine the
functional significance of these sites, truncation mutants of villin were constructed
as shown in figure 3.1C. The constructs consisted of amino-terminal deletions of
human villin cDNA engineered into the prokaryotic expression vector pGEX-4T1.
Five truncation mutants (CT-CT4) were generated as Gst-tagged fusion proteins
in TKX1 cells. The expression of full-length villin and the truncation mutants of
villin were assessed by SDS-PAGE and staining with GelCode Blue (figure
3.1D). The apparent molecular masses were in agreement with those predicted
for each deletion mutant. To assess tyrosine phosphorylation of these mutants,
the proteins were analyzed by western analysis using phosphotyrosine
antibodies (PY-20). All four truncation mutants were tyrosine phosphorylated

79

(figure 3.1D). These data suggested to us that each of the truncation mutants
contained one or more tyrosine phosphorylated residues. To identify these
phosphorylation sites, smaller truncation mutants were generated (CT5 and CT6,
figure 3.1C). Individual tyrosine residues in these shorter truncation fragments
(CT2, CT3, CT5 and CT6) were substituted with phenylalanine and the effect of
these mutations on the levels of phosphorylation was determined (Zhai et al.,
2002).

3.4.2 Identification of one major and two minor phosphorylation sites in
CT2. The truncation mutant of villin CT2 contains four tyrosine residues (Y-555,
-604, -681 and -725) between amino acids 533-827 of human villin that could be
phosphorylated. We used site-directed mutagenesis to substitute each of these
tyrosine residues with phenylalanine in the truncation mutant CT2. The mutants
were expressed in TKX1 cells, and the phosphorylation status of the mutant
proteins was analyzed by western analysis using an anti-phosphotyrosine
antibody (figure 3.2A). Densitometric analysis was done by determining the ratio
of phosphorylated protein to total protein for each sample. Mutation of Y725 to F
significantly decreased the level of tyrosine phosphoryaltion in the truncation
mutant CT2 (54.3 ± 3.3 %, n = 4, p < 0.001). In contrast mutation of Y555 or
Y604 to F decreased the level of tyrosine phosphorylation of the villin construct
CT2 to a lesser extent (25.0 ± 5.7 % and 37.5 ± 4.1 % respectively, n = 4, p <
0.001).

This suggested that CT2 contains one major (Y725) and two minor

(Y555 and Y604) tyrosine phosphorylated residues. To confirm this observation,
double mutants of these sites were generated in CT2 (figure 3.2B).
80

Figure 3.2 Identification of one major and two minor tyrosine phosphorylation
sites in villin truncation mutant CT2. (A) Mutant villin proteins were generated by
substitution of tyrosine residues at 555, 604, 681 or 725 with phenylalanine in
villin

truncation

mutant

CT2

[CT2(Y555F);

CT2(Y604F);

CT2(Y681F);

CT2(Y725F)]. The villin mutants were expressed as Gst-tagged phosphoryable
proteins in TKX1 cells. The samples were normalized for protein content and
subjected to SDS-PAGE and western analysis using phosphotyrosine antibody
(PY-20). (B) A villin mutant was generated by substituting two of the three
identified tyrosine phosphorylation sites in different combinations (CT2 (Y604F,
Y555F); CT2 (Y725F, Y604F); CT2 (Y725F, Y555F). Villin truncation mutant
CT2 as well as these phosphorylation site mutants were purified from TKX1 cells,
separated by SDS-PAGE and stained with GelCode Blue. western analysis was
done with a phosphotyrosine antibody. Tyrosine phosphorylation of CT2 and
phosphorylation site mutants of CT2 was quantified using Scion Image software.
The values for phosphorylation site mutants of CT2 were normalized to the
phosphorylation of truncation mutant CT2 (which was set as 100).

Statistically

significant values (compared with CT2) are marked with an asterisk (p < 0.001).
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Western analysis of the double mutants using phosphotyrosine antibodies
indicated essentially a complete loss of tyrosine phosphorylation with double
mutants Y725, 604F (91%, n = 4, p < 0.001) and Y725, 555F (81%, n = 4, p <
0.001).

In contrast, the double mutant Y604, 555F resulted in a relatively

smaller decrease in the total phosphorylation level in the truncation mutant CT2
(33.0 ± 5.3 %, n = 4, p < 0.001). These results indicate the presence of one
major and two minor sites in human villin protein between a.a. 533 and 827.

3.4.3 Identification of two major phosphorylation sites in villin truncation
mutant CT3. Villin truncation mutant CT3 contains three putative phosphoryable
tyrosine residues, Y286, Y296 and Y324. We mutated each of these tyrosine
residues to a phenylalanine and determined the effect of the mutation on the
levels of phosphorylation in the truncation mutant CT3. Equal amounts of the
proteins were separated by SDS-PAGE and western analysis done with
phosphotyrosine antibodies (PY-20). As shown in figure 3.3, mutation of Y286
as well as Y324 significantly decreased the levels of tyrosine phosphorylation in
the truncation mutant CT3 (99.0 ± 1.0 % and 65.9 ± 3.7 % respectively, n = 4, p <
0.001). On the other hand, mutation of Y296 to phenylalanine had no effect on
the phosphorylation levels of the truncation mutant CT3.

These data

demonstrate that in addition to Y555, Y604 and Y725, the carboxyl-terminal
domain of villin contains two additional tyrosine residues that can be
phosphorylated in vitro, namely Y286 and Y324.
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Figure 3.3 Tyrosine 286 and 324 are the major phosphorylation sites in the villin
truncation mutant CT3. Mutant villin proteins were generated by substitution of
tyrosine residues at 286, 296 or 324 with phenylalanine in villin truncation mutant
CT3 [CT3 (Y286F); CT3 (Y296F); CT3 (Y324F)].

The villin mutants were

expressed as Gst-fused phosphoryable proteins in TKX1 cells. The samples
were normalized for protein content and subjected to SDS-PAGE and western
analysis using phosphotyrosine antibody (PY-20). Tyrosine phosphorylation of
CT3 and phosphorylation site mutants of CT3 was quantified using Scion Image
software. The values for phosphorylation site mutants of CT3 were normalized to
the phosphorylation of truncation mutant CT3 (which was set as 100).
Statistically significant values (compared with CT3) are marked with an asterisk
(p < 0.001).
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3.4.4 Y461 is the major phosphorylation site in the villin truncation mutant
CT4.

As shown in figure 3.1D, the villin truncation CT4 is also tyrosine

phosphorylated suggesting that this truncation contains one or more tyrosine
residues that can be phosphorylated in vitro. Human villin contains 7 tyrosine
residues within this domain that could be phosphorylated in vitro. To determine
these sites of phosphorylation, we generated two additional truncation mutants,
CT5 and CT6, which encompass the amino acid residues between 373 and 533
(similar to CT4, figure 3.1 C). CT5 contains four tyrosine residues namely Y-422,
-427, -431 and -433. Mutation of either of these sites to phenylalanine resulted in
less than 5% decrease in the phosphorylation levels suggesting that these are
minor sites of phosphorylation, if at all, in the villin truncation CT4 (data not
shown). The truncation mutant CT6 contains three tyrosine residues namely, Y
-461, -444 and -470 and mutation of one of these residues, Y461, completely
(99%, n = 5, p < 0.001) abolished the phosphorylation in the truncation CT6
(figure 3.4A). To confirm that Y461 was the only major phosphorylation site in
CT4, we also generated a point mutant, Y461F, in CT4 (figure 3.4B).

The

expression and analysis of this mutant demonstrated that Y461 was the single
key phosphorylation site in CT4 (a.a. 373-534 of human villin). In conclusion, in
this study we have identified six tyrosine phosphorylation sites in the carboxylterminal domain of villin between a.a. 271-827 of human villin. All of these sites
are well conserved in villin across different species. Three of these sites are also
conserved among other proteins of the villin family including gelsolin, adseverin
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Figure 3.4 Identification of tyrosine residue 461 as the major phosphorylated
residue in villin truncation mutant CT4. (A) Mutant villin proteins were generated
by substitution of tyrosine residues at 444, 461 or 470 with phenylalanine in villin
truncation mutant CT6 [CT6 (Y444F); CT6 (Y461F); CT6 (Y470F)]. (B) Tyrosine
Y461 in villin truncation mutant CT4 was substituted with phenylalanine (CT4
(Y461F). The values for phosphorylation site mutants were normalized to the
phosphorylation of truncation mutant CT6 or CT4 (which was set as 100).
Statistically significant values are marked with an asterisk (p < 0.001). (C)
Sequence alignment of villin and related proteins of the villin superfamily. The
top panel shows alignment of villin sequences from human, mouse and chicken.
The bottom panel shows alignment of homologous sequences in gelsolin,
adseverin and CapG. (D) Substitution of all ten tyrosine residues at positions 46,
60, 81, 256, 286, 324, 461, 555, 604 and 725 with phenylalanine (VILT/WT
(AYFM)) eliminates tyrosine phosphorylation in full-length recombinant villin
protein.
(VILT/WT)

Tyrosine phosphorylation of full-length recombinant villin protein
was

compared

with

villin

mutant

VILT/WT(AYFM)

using

a

phosphotyrosine antibody or a phospho-villin antibody (VP-70782) described
previously (Tomar et al., 2004).

(E) Mutation of all ten identified tyrosine

residues abolishes tyrosine phosphorylation of villin in MDCK Tet-Off cells. Cell
extracts from MDCK Tet-Off cells stably transfected with VIL/FL or VIL/AYFM
were immunoprecipitated with phospho-villin antibody (VP-70782) and western
analysis done with phospho-tyrosine antibody.
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and CapG (figure 3.4C). Two of these sites Y324 and Y604 in human villin have
been identified as minor sites that are phosphorylated in human plasma gelsolin
(Y576 and Y624 respectively in gelsolin) (De Corte et al., 1999). Mutation of all
ten sites (VILT/WT(AYFM)) in villin, four previously identified (Y-46, -60, -81 and
-256) as well as the six sites identified in this study (Y-286, -324, -461, -555, -604
and -725) resulted in the complete loss of tyrosine phosphorylation in full-length
recombinant villin protein (figure 3.4D). These data were confirmed in MDCK TetOff cells stably transfected with this villin mutant lacking all ten identified tyrosine
phosphorylation sites (VIL/AYFM) (figure 3.4E). Collectively with our previous
study

we have now identified ten tyrosine residues in human villin that are

phosphorylated both in recombinant villin protein as well as in MDCK cells.
We also examined the stoichiometry of tyrosine phosphorylated villin in
MDCK cells expressing full-length villin (VIL/FL), villin mutant lacking the four
amino-terminal phosphorylation sites previously identified (VIL/ANFM), villin
mutant lacking the six carboxyl-terminal phosphorylation sites identified in this
study (VIL/ACFM) and a villin mutant lacking all ten identified tyrosine
phosphorylation sites (VIL/AYFM). MDCK cells stably expressing wild-type and
mutant villin proteins were lysed and immunoprecipitated using PY-20. Since the
commercially available villin monoclonal antibody cannot be used for
immunoprecipitation and since the phospho-villin antibody VP-70782 binds to
selective tyrosine phosphorylated epitopes of villin, we reasoned that a phosphotyrosine antibody would bind phosphorylated villin proteins with comparable
affinity.

We have previously demonstrated that PY-20 immunoprecipitates
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tyrosine phosphorylated villin protein (Khurana et al., 1997; Tomar et al., 2004).
Quantitative immunoprecipitation studies demonstrated that in MDCK cells
VIL/FL, VIL/ANFM and VIL/ACFM were tyrosine phosphorylated while villin
mutant VIL/AYFM was not (figure 3.5).

Densitometric analysis revealed that

mutation of the amino-terminal phosphorylation sites or the carboxyl-terminal
phosphorylation sites resulted in a 30.6 ± 12.22 and 56.79 ± 10.96 percent
decrease respectively in the phosphorylation levels of mutant villin proteins
compared to wild-type villin protein. Mutation of all ten tyrosine phosphorylation
sites (VIL/AYFM) resulted in the complete loss of phosphorylation of the villin
protein in MDCK cells (98.52 ± 0.47 percent decreased compared to VIL/FL).
These studies demonstrate that the ten tyrosine phosphorylation sites identified
in recombinant villin protein are also tyrosine phosphorylated in MDCK cells with
a comparable stoichiometry.

3.4.5 Functional significance of tyrosine phosphorylation sites identified in
the carboxy-terminus of villin. Each of the six tyrosine phosphorylation sites
identified in this study were mutated individually in full-length human villin cDNA
to

phenylalanine

(VILT/WT(Y286F);

VILT/WT(Y324F);

VILT/WT(Y461F);

VILT/WT(Y555F); VILT/WT(Y604F); VILT/WT(Y725F)), expressed in TKX1 cells
and purified as Gst-tagged tyrosine phosphorylated proteins. All six mutants
were tyrosine phosphorylated but lacked one of the identified tyrosine residues
(figure 3.6A). In order to assess whether the single point mutants maintained the
conformation of the wild-type villin protein, the unfolding profiles of wild-type
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Figure 3.5 Tyrosine phosphorylation of wild-type and mutant villin proteins. Cell
extracts

from

VIL/FL,

VIL/ANFM,

VIL/ACFM

and

VIL/AYFM

were

immunoprecipitated with phospho-villin antibody (VP-70782) and western
analysis done with phospho-tyrosine antibody PY-20 (upper panel). Middle panel
is a western blot with anti-villin monoclonal antibody and the bottom panel is a
western blot with anti-actin antibody.
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Figure 3.6 Regulation of actin dynamics by the carboxyl-terminal tyrosine
phosphorylation sites in villin. (A) Expression of full-length villin proteins with
point mutations at position 286, 324, 461, 555, 604 or 725. Tyrosine residues at
these positions were substituted with phenylalanine in full-length villin and
expressed as recombinant proteins in TKX1 cells. (B) Urea-induced, equilibriumunfolding transition of wild-type and mutant villin proteins.

Urea-induced

denaturation of wild-type and mutant villin proteins was measured by the change
in tryptophan fluorescence maxima at an excitation wavelength of 280 nm and an
emission scan from 300 to 420 nm. (C) Effect of wild-type and phosphorylation
site mutant villin proteins on the kinetics of actin polymerization. Pyrene-labeled
G-actin was incubated with VIL/WT, VILT/WT or mutant mutant villin proteins in
polymerization-inducing buffer, and fluorescence intensity was measured over
time. (D) Effect of wild-type and phosphorylation site mutant villin proteins on the
kinetics of actin depolymerization. Pyrene-labeled F-actin in the presence of
VIL/WT, VILT/WT or mutant villin proteins was diluted in actin depolymerizing
buffer, and the decrease in fluorescence intensity was followed over time. (E)
Effect of wild-type and phosphorylation site mutant villin proteins on the kinetics
of actin-capping. Polymerization of G-actin at barbed ends was nucleated by Factin (290 nM) seeds in the absence (control) or presence of non-phosphorylated
(VIL/WT), phosphorylated (VILT/WT) or mutant villin proteins.

91

92

and mutant villin proteins expressed in the absence of IAA (non-phosphorylated
proteins) as a function of the urea concentration were recorded by measuring the
intrinsic tryptophan fluorescence emission spectrum essentially as described
before (Kumar et al., 2004b).

The results indicate that single point mutants

express similar unfolding transitions as wild-type villin, thus maintaining a
comparable overall conformation as the wild-type recombinant villin protein
(figure 3.6B).

Full-length non-phosphorylated villin (VIL/WT), phosphorylated

villin (VILT/WT) and the phenylalanine substituted single point mutants were
used in a pyrene based actin-polymerization and -depolymerization assay as
described before (Zhai et al., 2002). As shown in figure 3.6C, the addition of
non-phosphorylated full-length villin (VIL/WT) increased the initial rate of actin
polymerization compared to the polymerization kinetics of actin alone (control). In
contrast, tyrosine phosphorylated full-length villin (VILT/WT) resulted in a lag
phase and decreased the rate of actin polymerization. This is consistent with our
previously published observation that tyrosine phosphorylation inhibits the actinnucleating function of villin (Zhai et al., 2001; Zhai et al., 2002; Kumar and
Khurana, 2004).

Mutation of any of the six identified phosphorylation sites

individually from Y to F, did not rescue the actin-nucleating property of nonphosphorylated full-length villin protein.

These data demonstrate that

phosphorylation at any five of the six identified tyrosine residues inhibits actin
nucleation by villin. Thus, like the amino-terminal phosphorylation sites, the
carboxyl-terminal phosphorylation sites also inhibit the actin-nucleating activity of
villin (Zhai et al., 2002). These studies suggest that the entire villin core and
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multiple tyrosine phosphorylation sites in the villin core could regulate actin
nucleation by villin.
Next we examined the effect of tyrosine phosphorylation of villin on F-actin
depolymerization.

Non-phosphorylated full-length villin protein (VIL/WT)

increased the depolymerization of F-actin compared with control samples (figure
3.6D). Furthermore, phosphorylation of villin enhanced its actin-depolymerizing
property, similar to our previous reports (Zhai et al., 2001; Zhai et al., 2002;
Kumar and Khurana, 2004). Mutation of Y286 to F resulted in actin severing by
villin comparable to that of non-phosphorylated full-length villin protein, while all
other mutants (Y324F, Y461F, Y555F, Y604F or Y725F) behaved like VILT/WT.
These data suggest that Y286 is the major phosphorylation site that regulates the
actin-depolymerizing function of villin. Taken together with our previous study,
we have now determined three tyrosine residues, namely Y46, Y60 and Y286, in
the amino-terminal domain (S1-S3) of villin that regulate its actin-depolymerizing
activity (Zhai et al., 2002).
The ability of VIL/WT, VILT/WT and the phosphorylation site mutants of
villin to bind to the plus or barbed end of actin filaments was tested by following
the polymerization kinetics of pyrene-labeled G-actin from barbed ends under
polymerization conditions where there is little or no growth from the pointed end.
The concentration of calcium (2.5 µM) used in this assay has been shown to be
saturating for capping but not severing of actin filaments by villin (Northrop et al.,
1986b).

As shown in figure 3.6E, addition of pyrene-labeled G-actin in the

presence of F-actin seeds results in significant and rapid actin polymerization
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over time. VIL/WT shows decreased rates of polymerization in the presence of
2.5 µM calcium, consistent with capped barbed ends. VILT/WT as well as the
phosphorylation site mutants of villin likewise capped the barbed ends of actin.
The inhibition of F-actin polymerization in the presence of 20 nM Cytochalasin D
confirms the fact that capping of the barbed end is indeed the cause of abolished
actin polymerization.

These data show that phosphorylated villin caps actin

filaments very similar to non-phosphorylated villin protein. Further these results
demonstrate that the actin-capping activity of villin is not regulated by tyrosine
phosphorylation.

3.4.6 Regulation of villin-induced cell migration by carboxyl-terminal
phosphorylation site mutants.

Because we have previously shown that

tyrosine phosphorylation of villin regulates cell migration, we examined the ability
of the carboxyl-terminal phosphorylation site mutants of villin to regulate this
function of villin (Tomar et al., 2004). For these studies, HeLa Tet-Off cells were
stably transfected with wild-type or the individual phosphorylation site mutants of
villin. Clones expressing comparable levels of wild-type and phosphorylation site
mutant proteins were selected for these studies (figure 3.7).
supplementary figure 3.7B

b1-b3

As shown in

and as reported previously, overexpression of

wild-type villin results in loss of stress fibers and redistribution of F-actin at or
near the cell surface compared with untransfected cells which appear more flat
and exhibit stress fibers (figure 3.7B a1-a3) (Tomar et al., 2004). Mutation of any of
the six carboxyl-terminal phosphorylation sites individually did not result in any
significant changes in either the distribution of villin or F-actin (figure 3.7B
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c-h).

Figure 3.7 Phosphorylation of villin at Y286, Y324, Y461, Y555, Y604 or Y725 is
not required for villin-induced changes in actin reorganization or cell shape
change. (A) HeLa Tet-Off cells were stably transfected with wild-type (VIL/FL)
and phosphorylation site point mutants of villin, namely VIL/Y286F; VIL/Y324F;
VIL/Y461F; VIL/Y555; VIL/Y604F; VIL/Y725F; or amino-terminal phosphorylation
site mutant (VIL/ANFM) or the carboxyl-terminal phosphorylation site mutant
(VIL/ACFM).

This figure shows representative clones of each villin construct

transfected in HeLa Tet-Off cells.
of the actin cytoskeleton.

(B) Villin expression results in reorganization

HeLa Tet-Off cells transfected with wild-type and

mutant villin proteins were analyzed by confocal microscopy. Double staining of
villin (a1-j1) and F-actin (a2-j2) was performed using villin monoclonal antibodies
(1:100) and Cy3 conjugated anti-mouse IgG (1:100) and Alexa-Phalloidin 488 (1
µg/ml), respectively. Composite images of villin (red) and F-actin staining (green)
are shown.

Merged images show co-localization of villin and F-actin (a3-j3).

Bars, 10 µm. (C) HeLa Tet-Off cells expressing equal amounts of wild-type or
phosphorylation site point mutants were used in wound-healing experiments.
All villin expressing cells (wild-type as well as mutants) migrated significantly
faster than villin null cells (p < 0.01, n = 24). VIL (-) cells refer to each clone
cultured in the presence of doxycycline, whereas VIL (+) refers to the same clone
cultured in the absence of doxycycline. The error bars are the measured SEM.
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Intracellular distribution of F-actin and villin were also examined in HeLa cells
expressing the villin mutants VIL/ACFM as well as VIL/ANFM.

Clones

expressing comparable levels of VIL/ACFM and VIL/ANFM were selected for
these studies (figure 3.7A). There was no significant change in either in the cell
morphology or the distribution of villin or F-actin in cells expressing VIL/ACFM
compared with VIL/FL (compare figure 3.7B

j1-j3

and figure 3.7B

b1-b3).

In contrast,

the villin mutant VIL/ANFM demonstrated a cell shape change consistent with
villin-null cells (figure 3.7B

i1-i3

and figure 3.7B

a1-a3).

This is similar to the

observation made with individual amino-terminal phosphorylation site mutants
(Tomar et al., 2004). Together with our previous studies, these data suggest that
changes in the microfilament structure and cell morphology are regulated by the
amino-terminal phosphorylation sites (Tomar et al., 2004). Next, we examined
the effects of these point mutants on villin-induced cell migration. Consistent with
our previous report, HeLa Tet-Off cells overexpressing wild-type (VIL +) villin
migrated faster than villin null cells (VIL -) (Tomar et al., 2004). The carboxylterminal phosphorylation site point mutants behaved like HeLa cells expressing
wild-type villin and individually did not regulate villin induced cell migration (figure
3.7C). To test the possibility that these sites may collectively be important to
villin’s function in cell migration, we examined the villin mutant lacking all six
carboxyl-terminal phosphorylation sites (VIL/ACFM). To our surprise, mutation of
all six carboxyl-terminal tyrosine residues to phenylalanine significantly inhibited
villin-induced increase in cell migration (figure 3.8A). The villin mutant VIL/ACFM
migrated significantly slower than VIL/FL and more like the villin-null cells
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Figure 3.8 Collectively the carboxyl-terminal tyrosine residues regulate villininduced cell migration. (A) Villin mutants lacking all four amino-terminal
phosphorylation sites (VIL/ANFM) or villin mutant lacking all six carboxyl-terminal
phosphorylation sites (VIL/ACFM) were cloned in pTRE- 6 x His and transfected
in HeLa Tet-Off cells. HeLa Tet-Off cells expressing equal amounts of VIL/FL,
VIL/ANFM, or VIL/ACFM, were used in a wound-healing assay. Cells expressing
VIL/WT migrate significantly faster than villin-null (VIL -) cells. VIL/ANFM and
VIL/ACFM, migrate like villin-null cells. The error bars are the measured SEM,
and the asterisk (*) denotes statistically significant values (p < 0.01, n = 24,
compared with VIL/FL). (B) The carboxyl-terminal phosphorylation sites in villin
regulate villin induced lamellipodia formation.

MDCK Tet-Off cells transfected

with SEYFP-tagged full-length (SEYFP/VIL), villin mutant lacking the aminoterminal phosphorylation sties (SEYFP/ANFM) or villin truncation mutant lacking
the carboxyl-terminal domain (SEYFP/S1-S3) were treated with EGF (50 ng/ml)
and time-lapse images recorded 5 min after the addition of EGF for a total of 35
min.

Bar 10 µm.

(C) Lamellipodial protrusion rates were determined as

described in Methods. Average velocity of lamellipod formation is denoted in
µm/min. The error bars are the measured SEM, and the asterisk (*) denotes
statistically significant values (p < 0.001, n = 10, compared with VIL/FL).
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(p < 0.01, n = 24). Likewise, mutation of all four amino-terminal phosphorylation
sites (VIL/ANFM) significantly (p < 0.01, n = 24) inhibited villin-induced cell
migration, consistent with our previous report (Tomar et al., 2004). Together with
our

previous

studies,

these

data

demonstrate

that

multiple

tyrosine

phosphorylation sites contained within the core are required for villin’s function in
cell migration. To further explore the mechanisms underlying the observations
described above, we generated a villin truncation mutant, S1-S3 (a.a. 1-338),
that lacks the second half of the villin core (S4-S6) as well as the headpiece (S7),
but retains the amino-terminal tyrosine phosphorylation sites. Full-length villin
(VIL), villin mutant lacking the carboxyl-terminal phosphorylation sites (ACFM),
as well as S1-S3 truncation mutant were transiently expressed as SEYFP-tagged
fusion proteins. All experiments were done 16 h post-transfection. MDCK Tet-Off
cells transiently transfected with SEYFP/VIL, SEYFP/ACFM as well as
SEYFP/S1-S3 were treated with LPA (1 µM) or EGF (50 ng/ml) and time lapse
images recorded every 2 min for 35 min. MDCK cells overexpressing full-length
villin and treated with EGF (50 ng/ml) show association of villin with the
lamellipodia (figure 3.8B). The association of villin with these cell surface
structures was tightly coupled to the growth of the lamellipodia and the forward
extension of the cell body . In contrast, MDCK Tet-Off cells overexpressing either
SEYFP/ACFM or SEYFP/S1-S3 villin did not form lamellipodia and demonstrated
little if any cell spreading during the 35 min of LPA/EGF treatment. In addition,
unlike the full-length villin protein, the truncation mutant S1-S3 was localized
diffusely to the cytosol (figure 3.8B). A similar observation was made in cells
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treated with LPA. Consistent with our previous report, time lapse images of
MDCK Tet-Off cells transfected with a the villin mutant lacking all four aminoterminal phosphorylation sites, SEYFP/ANFM, show no lamellipod formation in
response to EGF treatment (figure B.2A) (Tomar et al., 2004). We quantitated
these morphological changes by measuring the rate of lamellipodial protrusion
rate in MDCK Tet-Off cells expressing wild-type or mutant villin proteins
essentially as described before (Rottner et al., 1999; Athman et al., 2003).
MDCK cells expressing SEYFP/VIL demonstrated a significant increase in the
rate of lamellipodia formation (0.29 ± 0.008 µm/min) in MDCK cells expressing
SEYFP/VIL compared to SEYFP/ACFM (0.07 ± 0.003 µm/min) and SEYFP/S1S3 (0.03 ± 0.044 µm/min) (figure 3.8C). Similar observations were made in HeLa
Tet-Off cells transiently transfected with these plasmids. These data suggest that
optimal lamellipodia formation and maximum increase in cell migration following
EGF/LPA treatment occurred in cells expressing full-length villin compared with
cells expressing the amino-terminal phosphorylation site mutant, the carboxylterminal phosphorylation site mutant or the carboxyl-terminal truncation mutant of
villin. Together these data confirm our observation that like the amino-terminal
domain, the carboxyl-terminal domain of villin is also required for effective villininduced cell migration.

3.4.7 Tyrosine phosphorylation of carboxyl-terminal domain of villin is
required for its association with PLC-γ1.

Since the carboxyl-terminal

phosphorylation site mutants did not result in any significant changes in cell
shape or actin redistribution (figure 3.7, B.2), we speculated that the carboxyl102

terminal phosphorylation sites in villin may determine its interaction with ligands
that are crucial to cell migration. We have previously demonstrated that tyrosine
phosphorylated villin associates with PLC-γ1 and that PLC-γ1 is a major binding
partner of tyrosine phosphorylated villin in detergent-soluble fractions of cells
(Khurana et al., 1997; Panebra et al., 2001). More recently using fluorescence
resonance energy transfer (FRET) we have demonstrated the direct interaction
of villin with the SH2 domains of PLC-γ1 in living cells (Wang et al., Submitted).
Thus, PLC-γ1 is a physiologically significant ligand of tyrosine phosphorylated
villin (Wang et al., Submitted). Further, we have demonstrated that this
association of phospho-villin with PLC-γ1 is required for its function in intestinal
cell migration (Wang et al., Submitted). What was not reported in these studies
was the specific structural determinants in villin that establish its association with
PLC-γ1. Based on these previous studies, we hypothesized that the COOHterminal phosphorylation sites in villin may determine phospho-villin’s association
with PLC-γ1. To test this hypothesis, we examined the co-immunoprecipitation of
villin with PLC-γ1 in MDCK Tet-Off cells ectopically expressing VIL/FL,
VIL/ACFM, VIL/ANFM or VIL/AYFM. Using immunoprecipitated PLC-γ1 we
observed that tyrosine phosphorylated full-length villin associated with PLC-γ1 in
MDCK cells expressing wild-type villin protein (figure 3.9A). These data are
consistent with our previous reports demonstrating the association of tyrosine
phosphorylated villin with PLC-γ1 (Khurana et al., 1997; Panebra et al., 2001;
Wang et al., Submitted). In cells expressing VIL/ANFM PLC-γ1, formed a complex
with the mutant villin protein, indicating that amino-terminal phosphorylation sites
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Figure 3.9 Collectively the carboxyl-terminal tyrosine phosphorylation sites are
required for redistribution of villin to the detergent-soluble fraction and for its
association with PLC-γ1. (A) This figures shows co-immunoprecipitation of villin
with PLC-γ1 from the Triton X-100 soluble cell extracts.

(B) Distribution of villin

in detergent-soluble and insoluble cell fractions. Triton X-100-soluble fraction
(DS) and Triton X-100-insoluble (DI) fractions from MDCK cells transfected with
VIL/FL, VIL/ANFM VIL/ACFM or VIL/AYFM were immunoblotted with villin
monoclonal antibodies.

VIL/FL and VIL/ANFM distributes to the detergent-

soluble and -insoluble fraction, while villin mutants, VIL/ACFM as well as
VIL/AYFM distribute exclusively in the detergent-insoluble fraction. The western
blots are representative of three other experiments with similar results.
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are not involved in PLC-γ1

binding.

In contrast, in cells expressing either

VIL/ACFM or VIL/AYFM, PLC-γ1 did not form a complex with villin. All individual
point mutants of the carboxyl-terminal phosphorylation sites can associate with
PLC-γ1 (figure B.2B).

It may be noted that for these co-immunoprecipitation

studies PLC-γ1 was immunoprecipitated from the Triton X-100-soluble fraction of
cells. These data show that collectively the carboxyl-terminal tyrosine
phosphorylation sites determine villin’s association with PLC-γ1. In concurrence
with these immunoprecipitation studies, analysis of the detergent-soluble and
-insoluble pools indicated that wild-type villin protein was distributed both in the
Triton-soluble and Triton-insoluble fractions of the cell, as reported earlier
(Khurana et al., 1997). Likewise, VIL/ANFM protein was distributed both in the
detergent-soluble and -insoluble fractions of the cell.

In contrast, in cells

expressing either of the phosphorylation site mutants, VIL/ACFM or VIL/AYFM
the villin mutant proteins were almost exclusively distributed to the Triton X-100insoluble fraction and none of the mutant proteins were associated with
detergent-soluble cell fraction (figure 3.9B). This is noteworthy, since we have
previously demonstrated that the majority of the PLC-γ1 present in ileal villus
brush border is associated with the Triton-soluble fraction and not the detergentinsoluble fraction (Khurana et al., 1997). Further, we have also shown that the
tyrosine phosphorylated villin associates with PLC-γ1 in the detergent-soluble cell
fraction (Khurana et al., 1997). Taken together, these data suggest that the
carboxyl-terminal tyrosine phosphorylation sites in villin determine villin’s
distribution to the detergent-soluble cell fraction, where phosphorylation of these
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sites allows villin to form a complex with PLC-γ1 which is required for villininduced increase in cell migration (figure 3.10). While studying the SEYFP/S1S3 mutant that lacks the second half of villin core (S4-S6) as well as head piece
(S7), we made an interesting observation. We determined that longer
transfection times (>20 h) resulted in significant cell death in HeLa/MDCK Tet-Off
cells expressing the truncation mutant S1-S3 as noted by cell rounding and loss
of fluorescence, increase in TUNEL positive cells, chromatin condensation and
staining with Hoechst 33258 (figure B.3). For the same reason, stable cell lines
expressing S1-S3 could not be established for these studies. We speculate that
like gelsolin, the S1-S3 domain of villin results in unregulated actin severing and
apoptotic cell death (Kothakota et al., 1997). This may be important to villin’s
role as an anti-apoptotic protein and if villin is a substrate for caspases and/or
other proteases, the cleavage of villin into this fragment may have a regulatory
function (Wang, Y. and Khurana, S., unpublished observation).

Hence, the

carboxyl-terminal domain of villin may also be required to maintain a biologically
relevant conformation of villin that may be important to its functions as an antiapoptotic protein. Most importantly, the data presented in this study demonstrate
that the carboxyl terminal half of the villin core is not redundant as has been
suggested by some, but essential to villin’s function in cell migration and perhaps
cell death.
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Figure 3.10 Schematic representation of the role of the carboxyl-terminal
tyrosine phosphorylation sites in villin-induced cell migration. The panel on the
left shows resting cells in which villin associates with PIP2 at the plasma
membrane. In response to receptor activation including EGF treatment, villin is
tyrosine phosphorylated (by c-src kinase) and dissociates from PIP2 and binds
PLC-γ1 through its carboxyl-terminal phosphorylation sites. The association of
villin with PLC-γ1 at the plasma membrane results in the hydrolysis of PIP2 into
diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP3) (Wang et al.,
Submitted). IP3 releases Ca2+ from intracellular stores such as the endoplasmic
reticulum (ER). Both tyrosine phosphorylation as well as increase in intracellular
calcium induce actin-severing by villin resulting in actin remodeling and change in
cell morphology and increase in cell migration.
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3.5 Discussion
Metastases is the most lethal property of cancer cells and critical to this
property is the increased migratory state of tumor cells. The current thinking is
that cancer cells switch to a more motile state thus enhancing the metastatic
potential of a tumor cell. The molecular mechanisms that propel invasive growth
and metastases are also found during embryonic development and in adult tissue
maintenance such as wound repair. Most human cancers originate from epithelial
cells and include the major killers namely colon, breast and lung cancer.
Epithelial cell migration differs from that of fibroblasts in that epithelia migrate as
sheet such as during wound closure or as a tube such as during kidney
development in vertebrates. More recent studies have established that examining
epithelial cell migration in the context of proteins that are uniquely expressed in
epithelial cells including the actin binding protein villin

is important to our

understanding of this rather complex process (Athman et al., 2003; Wang et al.,
Submitted). We have demonstrated that overexpression of villin enhances cell
migration (Tomar et al., 2004). Likewise Athman et al have demonstrated that
villin enhances hepatocyte growth factor induced actin remodeling in epithelial
cells (Athman et al., 2003). Tyrosine phosphorylation of villin is essential to its
function in cell migration (Athman et al., 2003; Tomar et al., 2004). We have
previously reported that three tyrosine residues (Y60, Y81 and Y256) in the
amino-terminal domain of villin are required for villin-induced increase in cell
migration (Tomar et al., 2004). Phosphorylation at these three sites was shown to
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regulate the intracellular distribution of villin, the F-actin redistribution and
remodeling as well as villin-induced increase in cell migration (Tomar et al.,
2004). In this study we determined that in addition to these three amino-terminal
residues, the carboxyl-terminal tyrosine phosphorylation sites of villin are equally
important to its function in cell migration. While the tyrosine phosphorylation
sites in the amino-terminal half regulate villin-induced cell migration by regulating
the actin reorganization and cell morphology, the tyrosine phosphorylation sites
in the carboxyl-terminal half regulate villin’s ligand-binding properties, namely its
association with PLC-γ1. Mutation of all six carboxyl-terminal phosphorylation
sites in villin prevents the association of villin with PLC-γ1. The role of PLC-γ1 in
cell migration is undisputed. Overexpression of PLC-γ1 has been shown to result
in malignant transformation and has been implicated in the pathophysiology of
tumorigenesis (Soderquist et al., 1992; Nomoto et al., 1995; Chang et al., 1997;
Smith et al., 1998). Overexpression of PLC-γ1 is associated with progression of
colorectal tumors from normal mucosa to adenoma and then to carcinoma (Park
et al., 1994).

Growth factor mediated PLC-γ1 signaling is also required for

enhanced cell motility (Chen et al., 1994; Polk, 1998; Wells, 2000). For instance,
activation of PLC-γ1 downstream of HGF receptor activation is required for the
morphogenetic effects of HGF

during epithelial-mesenchymal transition

(Ponzetto et al., 1994; Gual et al., 2000). Redistribution of PLC-γ1 to the leading
edge and the activation of the phosphoinositide signal cascade at the leading
edge is likewise well documented (Chang et al., 1997; Chou et al., 2002; Piccolo
et al., 2002). Our study suggests that villin keeps the signal equilibrium of actin
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cytoskeleton organization, cell morphology and cell migration by utilizing distinct
domains and tyrosine phosphorylation sites within these domains in a differential
and cooperative way.
In this study we determined that villin mutant lacking the carboxyl-terminal
phosphorylation sites does not associate with the detergent-soluble fraction of
the cell thus preventing the association of phospho-villin with PLC-γ1. Likewise,
time-lapse

video

demonstrate

that

mutation

of

the

carboxyl-terminal

phosphorylation sites prevents villin’s localization to the lamellipodia.

A very

important step in cell locomotion is the development of a polarized phenotype
with the formation of a leading edge in the direction of cell movement. It has
been suggested that in addition to PI3-kinase, PLC-γ1 also determines the
polarized phenotype of a motile cell by its recruitment to the leading edge thus
regulating the first step of cell migration, namely the formation of a protrusion
(Chang et al., 1997; Chou et al., 2002; Piccolo et al., 2002). In fact, such an
observation has been made with cofilin, where inhibition of PLC inhibited the
effects of cofilin during the early stages of cell migration by delaying the initiation
of lamellipodia formation and inhibiting the ability of the cells to sense EGF
gradients (Mouneimne et al., 2004). In these studies, the authors determined
that both cofilin and PLC activation were required for the initial but not late
changes in the generation of free barbed ends, thus regulating cell migration.
Our own studies with PLC-γ1

-/-

and PLC-γ1

+/+

cells have demonstrated that

overexpression of villin and villin-induced increase in cell migration requires PLCγ1

(Wang et al., Submitted). Likewise, we have demonstrated that down
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regulation of PLC-γ1 using small, interfering, hairpin RNA (siRNA) prevents villininduced increase in cell migration (Wang et al., Submitted). Together, these
studies suggest that villin-induced increase in cell migration is likely regulated by
a rapid increase in actin polymerization at the leading edge which is enhanced by
tyrosine phosphorylation of villin and by the catalytic activation of PLC-γ1 by
phospho-villin. Thus, the synergistic interaction between tyrosine phosphorylated
villin and PLC-γ1 may drive the EGF stimulated lamellipod formation seen in our
studies. Together with our previous reports, data presented in this study show
that tyrosine phosphorylation sites in the carboxyl-terminal domain of villin are
important for villin’s ligand binding properties, specifically for its association with
PLC-γ1, thus regulating villin-induced cell migration (figure 3.10) (Panebra et al.,
2001).
Another interesting observation made in this study was the significance of
the carboxyl terminal domains of villin in maintaining a functionally relevant
protein conformation. Transient expression of S1-S3 fragment of villin in
HeLa/MDCK Tet-Off cells resulted in cell death (figure B.2). These studies
suggest that the S1-S3 fragment of villin might be functionally similar to the S1S3 fragment of gelsolin, which has been shown to be pro-apoptotic resulting in
cell death (Kothakota et al., 1997; Azuma et al., 2000). Further, these studies
suggest that the carboxyl-terminal half of the villin core may be functionally
similar to gelsolin domains S4-S6, in that these domains may be required to
maintain an autoinhibited conformation that prevents unregulated actin
depolymerization. It is also likely that releasing this conformation may be
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biologically relevant to the functions of these proteins in vivo. While a caspase-3
cleavage site has been identified in gelsolin that generates the pro-apoptotic S1S3 fragment, a similar caspase cleavage site or caspase-mediated cleavage of
villin is lacking, even though the villin fragment S1-S3 appears to be apoptotic
(Wang Y., and Khurana, S., unpublished observation) (Burtnick et al., 2004).
The pro-apoptotic functions of these two proteins could thus be regulated
differently as well. For instance gelsolin could be a substrate for caspase-3 while
villin could be a substrate for other proteases. Such proteolytic cleavage of villin
has been reported in enteric cells infected with Entamoeba histolytica (Lauwaet
et al., 2003). It may also be noted that in villin-gelsolin chimeras, where the S4S6 domains of villin were substituted with the second half of the gelsolin core,
failed to function like full-length villin protein, suggesting that while these two
proteins share significant structural and functional homology, they are not
identical (Finidori et al., 1992). This lends support to our view that proteins of this
family may have overlapping and yet distinct function(s) in tissues where more
than one member of this family is expressed such as in the intestine and kidney.
Our in vitro studies allowed us to identify the carboxyl-terminal
phosphorylation sites in villin. In addition, we determined that phosphorylation of
multiple carboxyl-terminal domain phosphorylation sites could regulate actinnucleation

by

villin,

while

phosphorylation

of

Y286

enhanced

actin-

depolymerization by villin. Further, we determined that tyrosine phosphorylation
of villin does not regulate its actin capping activity. Together with our previous
studies, these data confirm our observation that tyrosine phosphorylation
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regulates all but one actin regulatory activity of villin (Zhai et al., 2001; Zhai et
al., 2002; Tomar et al., 2004). While the carboxyl-terminal phosphorylation sites
regulated actin kinetics in vitro, mutation of these sites did not result in any
significant change in actin redistribution in the cell. The significance of these
changes is unclear at this point.
In addition to revealing new tyrosine phosphorylation sites as well as
identifying all phosphoryable tyrosine residues in villin, this study established the
domain functions of villin by investigating the ability of a series of mutants of villin
to rescue actin organization, cell morphology, and cell migration. These studies
determined that the amino terminal half of the core regulates actin reorganization
and cell shape while the entire villin core is required for cell migration. In this
report we demonstrate for the first time the functional relevance of the carboxylterminal tyrosine phosphorylation sites in villin, namely: in the distribution of villin
to the detergent soluble fraction; in the association of villin with its ligand PLC-γ1
in this fraction; in growth factor induced lamellipodia formation, hence in defining
the directionality of a polarized motile cell; and in the synergistic interaction with
PLC-γ1 to initiate the early steps involved in actin polymerization and assembly of
the lamellipodia in a moving cell. Elucidating the molecular mechanisms linking
the actin regulatory activities modified by phosphorylation of these sites with
villin’s function(s) will be the subject of future studies.
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Chapter 4
Discussion
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4.1 Tyrosine phosphorylation of villin and
actin kinetics
The work done in our lab has demonstrated that villin gets phosphorylated
both in vitro and in vivo (Khurana et al., 1997; Panebra et al., 2001). It was also
demonstrated that tyrosine phosphorylation of villin plays a vital role in the
biological properties of villin (Khurana et al., 1997; Panebra et al., 2001; Zhai et
al., 2001; Zhai et al., 2002). The next challenge was to identify the sites of
phosphorylation and to determine the role of the identified phosphorylation sites
in villin’s functions. The initial approach used to identify the sites of
phosphorylation was by mass spectrometry. However, this approach yielded a lot
of false positive results and the identified phosphorylation sites could not be
validated by mutational analysis. Since, the results obtained using mass
spectrometry would have required confirmation by mutational analysis, we
elected to identify the phosphorylation sites using the same approach namely,
mutational analysis. Tyrosine phosphorylated villin was generated in vitro using a
unique strategy employing Epicurian coli TKX1 cells. TKX1 cells carry a plasmid
with the elk tyrosine kinase (tk) gene controlled by the trp promoter. The elk
tyrosine kinase has broad specificity and has been shown to tyrosine
phosphorylate a number of eukaryotic proteins expressed in Epicurian coli TKX1
cells (Chin et al., 1996; Kozlowski et al., 1998). Human villin cDNA was cloned in
the prokaryotic expression vector pGEX-2T and a two-step protocol involving the
expression of human villin gene (by addition of IPTG) followed by the expression
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of the tk gene [by addition of 3- -indoleacrylic acid (IAA)], in Epicurian coli TKX1
cells resulted in generation of GST-tagged tyrosine-phosphorylated villin
(VILT/WT). We used site-directed mutagenesis to identify the tyrosine
phosphorylation sites in villin. We generated 10 truncations and approximately 50
individual point mutants (tyrosine to phenylalanine) of villin. A loss of signal in
quantitative western blots, probed with a phospho-tyrosine specific antibody (PY20), in individual Y to F point mutants allowed us to identify putative tyrosine
phosphorylation sites in villin (Zhai et al., 2002). Using this approach four
phosphorylation sites were identified in the amino-terminus of human villin,
namely Y-46, -60, -81, and -256. The identified sites were also substrates of csrc kinase in vitro (Zhai et al., 2002). Interestingly, we noted that mutation of the
four amino terminus tyrosine phosphorylation sites (to phenylalanine) still
resulted in villin phosphorylation, indicating the presence of additional
phosphorylation sites in the carboxyl-terminus of villin (Tomar et al., 2006). I used
the same approach (as described above) to identify six additional tyrosine
phosphorylation sites in the carboxyl-terminus of human villin, namely, Y-286,
-324, -461, -555, -604 and -725. All ten identified tyrosine phosphorylation sites
are well conserved across species. Y-46, -256, -286, -324, -461, -555, and -604
are also well conserved in other proteins of the villin family, including gelsolin,
adseverin and cap G (table 4.1). To confirm that all the phosphorylation sites in
villin had been identified we generated a villin mutant with all ten identified
tyrosine residues mutated to phenylalanine (VIL/AYFM). VIL/AYFM was not
phosphorylated

when

expressed
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as

a

recombinant

protein
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adseverin, and CapG.

from human, mouse and chicken. Bottom panel shows alignment of homologous sequences from gelsolin

Comparison of sequences from villin and related proteins. Top panel shows alignment of villin sequences

Table 4.1 Sequence alignment of villin and related proteins of villin super family.

using Epicurian coli TKX1 cells. VIL/AYFM was also not phosphorylated when
expressed in HeLa and MDCK Tet-off cells (chapter 3).
The next task was to map phosphorylation at each of these sites with
villin’s actin regulatory functions. For these studies we used muscle actin as a
source of pyrene labeled G-actin or F-actin. Each of the ten identified
phosphorylation sites were mutated individually (to phenylalanine) in full-length
villin and the role of these sites on villin’s actin modifying functions was
determined in vitro. From these studies we determined that tyrosine
phosphorylation of villin enhanced actin-severing, inhibited -nucleation and
-bundling functions of villin but had no effect on the actin-capping activity of villin.
Further, we established that phosphorylation at residues 46, 60 and 286
enhanced the actin-severing activity of villin. Mutation of any one of the ten
identified phosphorylation sites had no effect on the actin nucleating function of
phospho-villin. Thus, two or more phosphorylation sites regulate the actinnucleating function of villin (table 4.2).

4.2 A summary of villin’s role

in

cell

migration
Cell migration is regulated by correct spatial and temporal organization of
actin filaments, which is determined largely by the actin binding proteins. Villin is
one of the most versatile actin binding protein in epithelial cells, as it can regulate
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Table 4.2 Tyrosine phosphorylation of villin and its role in actin kinetics.

Actin-severing is enhanced by phosphorylation at residues, 46, 60 and 286. aTwo
or more of the identified tyrosine residues regulate actin-nucleation by villin.
Tyrosine phosphorylation does not regulate actin-capping activity of villin.
b

Tyrosine phosphorylation of villin inhibits actin-bundling but the specific residues

regulating this function have not been identified.

119

actin-nucleation, -severing, -capping and -bundling. As discussed earlier,
(chapters 2 and 3) overexpression of villin in intestinal and renal epithelial cells
enhanced the rate of both basal as well as growth factor induced cell migration.
Further, we demonstrated that tyrosine phosphorylation of villin was required for
villin’s function in cell migration. Tyrosine phosphorylation of villin as well as villininduced cell migration was also significantly inhibited by overexpression of a
dominant negative mutant of c-src kinase, confirming the significance of tyrosine
phosphorylated villin in the regulation of cell migration (chapter 2). As
summarized in table 4.2, we have identified 10 tyrosine residues in villin that are
phosphorylated. Interestingly all but one of the phosphorylation sites enhanced
villin-induced cell migration (Y-46 to -F had no effect). The amino-terminus
phosphorylation sites (Y-60, -81 and -256) regulated villin’s intracellular
distribution, actin reorganization and changes in cell morphology thus, regulating
villin-induced cell migration (chapter 2). In contrast, phosphorylation of the
carboxyl-terminus sites (Y-286, -324, -461, -555, -604, and -725) had no effect
on villin-induced changes in actin reorganization or cell morphology, but were
found to be critical for villin’s interaction with its ligand PLC-γ1. The role of PLC-γ1
in cell migration is well documented (chapter 3). The role of all ten identified
tyrosine phosphorylation sites in villin-induced cell migration has been
summarized in table 4.3.
As discussed in chapter 1, the formation and growth of lamellipodia in a
motile cell requires actin polymerization. Severing of existing filaments,
uncapping of existing filaments or de novo nucleation can all enhance actin
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Table 4.3 Tyrosine phosphorylation of villin and its role in cell migration.

The role of all ten identified tyrosine phosphorylation sites in cell migration is
summarized.

a

More than one tyrosine phosphorylation site is involved in

interaction with PLC-γ1. bMutation of Y-46 to -F had no effect on cell migration,
however mutation of Y-46 to -E inhibited cell migration (Chapter 2).
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polymerization. Tyrosine phosphorylated villin can sever F-actin to provide new
actin nuclei thus enhancing actin polymerization. Tyrosine phosphorylation of
villin does not regulate the capping activity of villin and inhibits the nucleating
activity of villin. Hence, we speculate that severing of actin filaments by villin can
provide new nuclei for elongation at the leading edge. As discussed in chapter 1,
the current thinking is that de novo nucleation at the leading edge, primarily by
Arp2/3 complex, is crucial for generation of new filaments and cell migration.
However, some recent studies have suggested that a synergy between actinsevering proteins like cofilin and Arp2/3 is required for optimal generation of
barbed ends at the leading edge of moving cells (Chan et al., 2000; Bailly et al.,
2001). The function-blocking antibodies directed against either cofilin or Arp2/3
significantly decreased barbed-end generation and cell protrusion (Chan et al.,
2000; Bailly et al., 2001). Further, it has also been demonstrated that the
severing activity of cofilin and nucleating activity of Arp2/3 alone, caused only a
modest increase in actin polymerization. However, together they significantly
enhanced actin polymerization, suggesting a role for both proteins in cell
migration (Ichetovkin et al., 2000). A similar argument has been made for the
interaction between the Arp2/3 complex and gelsolin in platelets and fibroblasts,
in which new actin nuclei generated by the severing activity of gelsolin has been
proposed to be necessary for the activity of the Arp2/3 complex (Falet et al.,
2002).These studies indicate that the severing activity of actin-binding proteins
like cofilin, gelsolin and by analogy villin may be necessary for optimal actin
nucleation by the Arp2/3 complex. It is suggested that the actin nucleating activity
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of the Arp2/3 complex is enhanced because the severing activity of proteins such
as cofilin and gelsolin generates new barbed ends, which are the preferred sites
for binding of the Arp2/3 complex, compared with older, ADP-containing
filaments (DesMarais et al., 2005). Hence, depending on the cell type, different
actin severing proteins may act synergistically with Arp2/3 to regulate cell
migration. This synergistic interaction between actin severing proteins and Arp2/3
is also important for providing directionality, as actin severing and generation of
new nuclei at the leading edge would determine the sites of dendritic nucleation
and therefore the site of membrane protrusion (DesMarais et al., 2005).
For future studies, it would be interesting to examine the role of Arp2/3
complex in villin-induced cell migration, to ask such questions as: can villin
regulate cell migration in cells where Arp2/3 is inactivated? In the absence of
Arp2/3 activity do villin expressing cells form primarily lamellipodia (cross-linked
actin) or filopodia (bundled actin)? If not, then is there a synergy between Arp2/3
complex and villin during epithelial cell migration? Is villin targeted to the leading
edge before or after Arp2/3? Does the role of villin in phosphoinositide signalling
play any role in activation of Arp2/3 complex and its targeting to the leading
edge? Similarly it would also be important to examine the role of Rho GTPases,
specifically Rac and Cdc42 in villin induced cell migration. The answers to these
and similar questions would help establish the precise role that villin plays in
concert with other proteins at the leading edge during epithelial cell migration.
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4.3

Tyrosine

phosphorylation

of

villin:

Leading the way in epithelial cell migration
In chapter 1 the original steady-state “dendritic model” has been
discussed. In this model actin severing proteins like cofilin, gelsolin or villin are
proposed to function exclusively as actin-recycling factors, depolymerizing
filaments to yield G-actin, but not as severing proteins that could generate new
nuclei for filament assembly during cell migration. Moreover, the model does not
take into account the synergistic interactions between actin-severing proteins and
Arp2/3 complex, which are now reasonably well established. Hence, the steadystate “dendritic model” fails to justify the role of actin-severing proteins in cell
migration. More recently a new model of cell migration has been described which
takes into consideration the synergistic interaction of actin-severing proteins with
Arp2/3 complex and is called the “stimulated protrusion model” (DesMarais et
al., 2005). This model proposes that the severing activity of actin-binding proteins
at the leading edge determines the site of barbed end formation hence,
determining the site of dendritic nucleation and therefore the site of membrane
protrusion (figure 4.1). It is therefore reasonable to speculate that since villin is
the most abundant actin-severing protein of its family in intestinal and renal
epithelial cells, and the only actin severing protein expressed in microvilli of
epithelial cells, it could regulate cell migration by generating new actin nuclei at
the leading edge. These severed actin filaments could then act as sites of
dendritic nucleation, thus determining the site of membrane protrusion.
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1

2

3

4

Plasma membrane
profilin

ATP-G-actin

Arp2/3 complex

ADP-G-actin

Capping protein

Actin severing protein
ABP

Figure 4.1 Stimulated protrusion model. (1) Under resting condition the actin
severing protein is not activated. (2) The localized activation of actin severing
protein generates free barbed end. (3) Profilin bound ATP-G-actin is added to the
barbed end, generating ATP actin cap, where activated Arp2/3 complex binds
and initiates branch formation. (4) Rapid growth occurs at the barbed end of actin
filaments which pushes the membrane forward.
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Hence, like cofilin, villin could serve as a dynamic component of the steering
wheel in a moving cell.
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Figure A.1 There is no change in cell proliferation in HeLa cells expressing wildtype and mutant villin proteins. Cell proliferation was measured in HeLa cells
stably transfected with wild-type and mutant villin proteins. Cells were cultured in
low serum (1.0% fetal bovine serum) similar to those used for cell migration
studies. Cell proliferation was detected using BrdU immunostaining. Data are
representative of three experiments with similar results. Bar, 50 µm
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Figure A.2 There is no change in villin-induced cell migration in HeLa Tet-Off
cells infected with recombinant adenovirus vector. VIL/FL and VIL/NULL cells
were infected with recombinant adenovirus (Ad-EGFP (vector alone, control) for
4 hours at a multiplicity of infection (m.o.i.) of 100. Virus-containing media was
then removed and cells were cultured for an additional 18 hours to allow for
expression of transgenic proteins. This was followed by measurement of cell
migration. The error bars are the measured SEM and the asterisk (*) and denote
statistically significant values (p < 0.05, n = 24, compared with VIL (-) cells).
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Figure A.3 Tyrosine phosphorylation of villin is required for villin-induced
increase in cell migration. HeLa cells were stably transfected with wild-type
(VIL/FL) and phosphorylation site mutants of villin, namely Y46F, Y60F, Y81F
and Y256F. HeLa cells transfected with wild-type (VIL/FL) and mutant villin
proteins were analyzed by confocal microscopy. Double staining of villin (a2-f2)
and F-actin (a1-f1) was performed using villin monoclonal antibodies (1:100) and
FITC conjugated anti-mouse IgG (1:200) and Alexa Phalloidin 568 (1 µg/ml)
respectively. Composite images of villin (green) and F-actin staining (red) are
shown. Merged images (a3-f3) show co-localization of villin and F-actin. Wildtype villin and VIL/Y46F co-localize with F-actin at the cell periphery. In contrast
phosphorylation mutants of villin VIL/Y60F, VIL/Y81F, and VIL/Y256F show
intracellular distribution of villin and F-actin with minimal colocalization of villin
and F-actin at the cell surface. Bars, 10 µm.
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Figure A.4 Overexpression of villin does not change the F-actin content of the
cells. HeLa cells expressing wild-type and mutant-villin proteins were cultured to
confluence and then denuded using a pipette tip to generate 20 wounds per dish.
The cells were fixed, permeabilized and stained with Alexa Phalloidin 568 and
ethidium bromide. After scraping the cells in methanol, the Alexa Phalloidin and
ethidium bromide were quantified using a spectrofluorometer at excitation of 525
nm and emission of 605 for DNA and excitation wavelength of 578 nm and
emission of 600 nm for F-actin. The F-actin content was quantified as the ratio of
Alexa Phalloidin fluorescence intensity to ethidium bromide fluorescence
intensity.
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Figure A.5 Phosphorylation of villin at Y-60, Y-81 and Y-256 is required for villininduced cell migration. A. HeLa cells were stably transfected with wild-type
(VIL/FL) and phosphorylation site mutants of villin, namely Y46E, Y60E, Y81E
and Y256E. This figure shows representative clones of each villin construct
transfected in HeLa cells. Data are representative of six experiments with similar
results. B. Villin expression results in reorganization of the actin cytoskeleton.
HeLa cells transfected with wild-type (VIL/FL) and mutant villin proteins were
analyzed by confocal microscopy. Double staining of villin and F-actin was
performed using villin monoclonal antibodies (1:100) and FITC conjugated antimouse IgG (1:200) and Alexa Phalloidin 568 (1 µg/ml) respectively. Composite
images of villin (green) and F-actin staining (red) are shown. Merged images
show co-localization of villin and F-actin (a3-f3). Wild-type villin and VIL/Y60E,
VIL/Y81E, and VIL/Y256E co-localize with F-actin at the cell periphery. In
contrast a phosphorylation mutant of villin VIL/Y46E shows intracellular
distribution of villin and F-actin with minimal co-localization of villin and F-actin at
the cell surface. Bars, 3 µm. C. HeLa cells expressing equal amounts of wild-type
and phosphorylation site mutants (Y to E) of villin were used in wound-healing
experiments. The error bars are the measured SEM, and the asterisk (*) and
cross (†) denote statistically significant values (p < 0.05, n = 24, compared with
VIL (-) cells) and (p < 0.05, n = 24, compared with untreated cells) respectively.
VIL (-) refers to each clone cultured in the presence of doxycycline while VIL (+)
refers to the same clone cultured in the absence of doxycycline.
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4

Permission to reproduce by The American Society for Biochemistry and
Molecular Biology. Tomar, A., George, S., Kansal, P., Wang, Y., and Khurana, S.
(2006). Interaction of phospholipase C-γ1 with villin regulates epithelial cell
migration. J. Biol. Chem. 281, 31972-31986.
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Figure B.1 Individually, the carboxyl-terminal tyrosine phosphorylation sites
mutants are not associated with PLC-γ1. (A) MDCK Tet-Off cells transfected with
SEYFP-tagged amino-terminal phosphorylation site mutant (SEYFP/ANFM) were
treated with EGF (50 ng/ml) and time-lapse images recorded 5 min after the
addition of EGF for a total of 35 min. These cells do not form lamellipodia or
membrane ruffles in response to EGF treatment. (B) Triton-X-100 soluble cell
extracts from HeLa Tet-Off cells stably transfected with wild-type (VIL/FL) and
phosphorylation site point mutants of villin, namely VIL/Y286F; VIL/Y324F;
VIL/Y461F;

VIL/Y555;

VIL/Y604F

and

VIL/Y725F

were

used

for

co-

immunoprecipitation of villin with PLC-γ1. These data show that VIL/FL as well as
the phosphorylation site point mutants of villin associate with PLC-γ1.
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Figure B.2 S1-S3 fragment of villin is pro-apoptotic. (A) HeLa Tet-Off cells
transiently transfected with SEYFP/S1-S3. Images were collected 16, 20 and 24
hours post-transfection using a confocal microscope, LSM 5 PASCAL (Carl
Zeiss, Thornwood, NY).

At 16 h post-transfection cells demonstrate good

expression of the S1-S3 fragment of human villin. Unlike full-length villin, this
truncation mutant shows diffuse cytosolic localization. At 20 h post-transfection
some of the cells are rounded-up (arrow head); and at 24 h post-transfection
almost all the cells expressing S1-S3 are rounded, detached and there is a
significant loss of fluorescence indicating increased cell death.

(B) MDCK Tet-

Off cells transiently transfected with SEYFP/S1-S3 were incubated with
HOECHST 33258 as described in materials and methods. Apoptotic cells were
distinguished from viable cells by nuclear condensation and DNA fragmentation
seen as bright blue fluorescence in the nuclei indicated by arrow heads. The
apoptotic cells showing bright blue fluorescence also express SEYFP/S1-S3 and
the bright field image indicates that the SEYFP/S1-S3 expressing cells also show
more rounded morphology. (C) MDCK Tet-Off cells transiently transfected with
VIL/S1-S3 cDNA cloned in pTRE HA or vector pTRE HA alone (Control) were
analyzed for apoptotic-induced DNA fragmentation using a colorimetric ELISA kit
as described in methods, SEM (p < 0.01, n = 6).
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Glossary
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A
a.a.
Ad
Blot
BrdU
Ca2+
Cyt D
DAG
DN
E
EGF
ER
F
HGF
IAA
IP
IP3
IPTG
K
Kd
kDa
LPA
Mg2+
PI
PIP
PIP2
PKC
PLC-γ1
PP2
PP3
R
SEYFP
VIL/ACFM
VIL/ANFM
VIL/AYFM
VIL/FL
VIL/WT
VILT/WT
X
Y

Alanine
amino acid (human unless otherwise stated)
Adenovirus
Immunoblotting
Bromodeoxyuridine
Calcium
Cytochalasin D
Diacyl glycerol
Dominant negative
Glutamic acid
Epidermal growth factor
Endoplasmic reticulum
Phenylalanine
Hepatocyte growth factor
3-β-indoleacrylic acid
Immunoprecipitation
Inositide tri phosphate
Isopropyl β-D-thiogalactopyranoside
Lysine
Dissociation constant
Kilo Dalton
Lysophosphatidic acid
Magnesium
Phosphatidylinositol
Phosphatidylinositol 4-monophosphate
Phosphatidylinositol 4,5-bisphosphate
Protein kinase C
Phospholipase C-gamma-1
4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d) pyrimidine
4-amino-7-phenylpyrazolo(3,4-d)pyrimidine
Arginine
Super enhanced yellow fluorescent protein
Villin mutant lacking all six carboxyl-terminal phosphorylation sites
Villin mutant lacking all four amino-terminal phosphorylation sites
Villin mutant lacking all ten tyrosine phosphorylation sites
Full-length human villin
Full-length recombinant human villin;
Full-length recombinant human tyrosine-phosphorylated villin
Any amino acid
Tyrosine
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